EP2287614A1 - Halbleiternanokrystallinesonden für biologischen Anwendungen - Google Patents

Halbleiternanokrystallinesonden für biologischen Anwendungen Download PDF

Info

Publication number
EP2287614A1
EP2287614A1 EP10010743A EP10010743A EP2287614A1 EP 2287614 A1 EP2287614 A1 EP 2287614A1 EP 10010743 A EP10010743 A EP 10010743A EP 10010743 A EP10010743 A EP 10010743A EP 2287614 A1 EP2287614 A1 EP 2287614A1
Authority
EP
European Patent Office
Prior art keywords
semiconductor nanocrystal
energy
probe
semiconductor
proximal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP10010743A
Other languages
English (en)
French (fr)
Other versions
EP2287614B1 (de
Inventor
Shimon Weiss
Marcel Bruchez
Paul Alvisatos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22987308&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP2287614(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by University of California filed Critical University of California
Publication of EP2287614A1 publication Critical patent/EP2287614A1/de
Application granted granted Critical
Publication of EP2287614B1 publication Critical patent/EP2287614B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L33/00—Semiconductor devices having potential barriers specially adapted for light emission; Processes or apparatus specially adapted for the manufacture or treatment thereof or of parts thereof; Details thereof
    • H01L33/005—Processes
    • H01L33/0062—Processes for devices with an active region comprising only III-V compounds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/02—Use of particular materials as binders, particle coatings or suspension media therefor
    • C09K11/025—Use of particular materials as binders, particle coatings or suspension media therefor non-luminescent particle coatings or suspension media
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/56—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing sulfur
    • C09K11/562—Chalcogenides
    • C09K11/565—Chalcogenides with zinc cadmium
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/88—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing selenium, tellurium or unspecified chalcogen elements
    • C09K11/881—Chalcogenides
    • C09K11/883—Chalcogenides with zinc or cadmium
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/89—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing mercury
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/89—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing mercury
    • C09K11/892—Chalcogenides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/588—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with semiconductor nanocrystal label, e.g. quantum dots
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L33/00—Semiconductor devices having potential barriers specially adapted for light emission; Processes or apparatus specially adapted for the manufacture or treatment thereof or of parts thereof; Details thereof
    • H01L33/005—Processes
    • H01L33/0083—Processes for devices with an active region comprising only II-VI compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/141111—Diverse hetero atoms in same or different rings [e.g., alkaloids, opiates, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]

Definitions

  • semiconductor nanocrystal compound is intended to define one or more semiconductor nanocrystals linked to one or more first linking agents and capable of linking to either one or more second linking agents or to one or more affinity molecules
  • semiconductor nanocrystal probe is intended to define a semiconductor nanocrystal compound linked to one or more affinity molecules
  • the semiconductor nanocrystals may also include alloys comprising two or more semiconductors selected from the group consisting of the above Group III-V compounds, Group II-VI compounds, Group IV elements, and combinations of same.
  • the emission wavelength by varying the composition, or alloy, of the semiconductor nanocrystal is old in the art.
  • a CdS semiconductor nanocrystal having an emission wavelength of 400 nm
  • a CdSe semiconductor nanocrystal having an emission wavelength of 530 nm.
  • the wavelength of the emission from a plurality of identically sized nanocrystals may be tuned continuously from 400 nm to 530 nm depending on the ratio of S to Se present in the nanocrystal.
  • SiO x silica glass
  • each probe may contain a plurality of semiconductor nanocrystals, all bound to a single three-dimensional linking agent in the same probe (e.g., blue-green probe, green-red probe, blue-red probe, blue-green-red probe).
  • a three-dimensional linking agent e.g., blue-green probe, green-red probe, blue-red probe, blue-green-red probe.
  • Still further increases in combinations of semiconductor nanocrystals bonded to a three-dimensional linking agent structure can be achieved by varying the number of identically emitting semiconductor nanocrystals bonded to the three-dimensional linking agent in the same probe in order to provide different intensities of detectable signals (e.g.
  • the three-dimensional linking agent structure may comprise an organic or inorganic structure, and may be a porous or non-porous solid, or hollow.
  • the semiconductor nanocrystal may be embedded therein, while the semiconductor nanocrystal may be encapsulated in a hollow three-dimensional linking agent structure.
  • the material comprising the linking agent must both (1) allow a first energy to be transferred from an energy source to the one or more semiconductor nanocrystals (exposing the semiconductor nanocrystal to energy), and (2) allow a second energy, provided by the one or more semiconductor nanocrystals in response to exposure to the first energy, to be either detected or transferred to a proximal structure.
  • the organic material may comprise, for example, one or more resins or polymers.
  • the semiconductor nanocrystals may be linked to the three-dimensional linking agent by physically mixing the semiconductor nanocrystals with the resin(s) or polymer(s), or may be mixed with the monomer(s) prior to polymerization of the monomer(s) to form the polymer(s).
  • the semiconductor nanocrystals may be linked to the three-dimensional linking agent by covalent bonding to either the monomer or the resin or polymer, or the semiconductor nanocrystals may be linked to the three-dimensional linking agent by adsorption (adherence to the exterior) or absorption (embedded, at least partially, into the interior).
  • probes whose substructures are assembled in different arrangements may be distinguished.
  • a probe which comprises red, green and blue semiconductor nanocrystal substructures ordered in an onion-like arrangement may be distinguished from a probe which comprises red, green, and blue semiconductor nanocrystal substructures ordered in a soccer ball-like arrangement.
  • proximal structure may be an atom, a molecule, or any other substance (e.g. a polymer, a gel, a lipid bilayer, and any substance bonded directly to a semiconductor nanocrystal probe) which is capable of receiving energy transferred from another atom or molecule or other substance (including a semiconductor nanocrystal probe).
  • Energy transfer from one or more semiconductor nanocrystal probes to one or more proximal structures may take place in a manner similar to any of the previously described transfers of energy from one or more proximal sources to one or more semiconductor nanocrystal probes. Therefore, a semiconductor nanocrystal probe may transfer energy to a proximal structure by way of radiative or non-radiative (e.g., FRET) pathways.
  • the energy transferred from a semiconductor nanocrystal probe to a proximal structure by a radiative pathway may include particle and electromagnetic radiation.
  • the energy transfer from a semiconductor nanocrystal probe to a proximal structure may occur as a result of energy transferred from an energy source separate from the semiconductor nanocrystal probe.
  • a semiconductor nanocrystal probe having one or more nucleic acid monomers as its affinity molecule portion, may serve as a precursor (primer) in a process for synthesizing DNA in large amounts, such as polymerase chain reaction (PCR); and the final PCR product may be a modified semiconductor nanocrystal probe having an affinity molecule with a greater number of nucleic acid monomers than the affinity molecule of the precursor semiconductor nanocrystal probe.
  • the synthetic steps to which the semiconductor nanocrystal probe may be subjected include, for example, any method of nucleic acid synthesis (by use of the term, "nucleic acid synthesis" it is meant any enzymatic process of synthesizing nucleic acid strands using nucleic acid monomers).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Materials Engineering (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Inorganic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Power Engineering (AREA)
  • Microelectronics & Electronic Packaging (AREA)
  • Computer Hardware Design (AREA)
  • Manufacturing & Machinery (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP10010743.2A 1999-03-01 2000-02-28 Halbleiternanokrystallinesonden für biologischen Anwendungen Expired - Lifetime EP2287614B1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/259,982 US6207392B1 (en) 1997-11-25 1999-03-01 Semiconductor nanocrystal probes for biological applications and process for making and using such probes
EP09014899.0A EP2180321B1 (de) 1999-03-01 2000-02-28 Halbleiternanokrystallinesonden für biologischen Anwendungen
EP00915944A EP1166118A1 (de) 1999-03-01 2000-02-28 Halbleiternanokrystallinesonden für biologischen anwendungen

Related Parent Applications (3)

Application Number Title Priority Date Filing Date
EP00915944.3 Division 2000-02-28
EP09014899.0A Division-Into EP2180321B1 (de) 1999-03-01 2000-02-28 Halbleiternanokrystallinesonden für biologischen Anwendungen
EP09014899.0 Division 2009-12-01

Publications (2)

Publication Number Publication Date
EP2287614A1 true EP2287614A1 (de) 2011-02-23
EP2287614B1 EP2287614B1 (de) 2013-08-07

Family

ID=22987308

Family Applications (3)

Application Number Title Priority Date Filing Date
EP09014899.0A Expired - Lifetime EP2180321B1 (de) 1999-03-01 2000-02-28 Halbleiternanokrystallinesonden für biologischen Anwendungen
EP10010743.2A Expired - Lifetime EP2287614B1 (de) 1999-03-01 2000-02-28 Halbleiternanokrystallinesonden für biologischen Anwendungen
EP00915944A Ceased EP1166118A1 (de) 1999-03-01 2000-02-28 Halbleiternanokrystallinesonden für biologischen anwendungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP09014899.0A Expired - Lifetime EP2180321B1 (de) 1999-03-01 2000-02-28 Halbleiternanokrystallinesonden für biologischen Anwendungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP00915944A Ceased EP1166118A1 (de) 1999-03-01 2000-02-28 Halbleiternanokrystallinesonden für biologischen anwendungen

Country Status (6)

Country Link
US (11) US6207392B1 (de)
EP (3) EP2180321B1 (de)
JP (2) JP4601828B2 (de)
AU (1) AU3712700A (de)
CA (1) CA2366303C (de)
WO (1) WO2000055631A1 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9284188B2 (en) 2010-09-03 2016-03-15 The Regents Of The University Of California Cytosolic delivery of materials with endosome-disrupting colloids
CN111051884A (zh) * 2017-05-18 2020-04-21 轨迹农业Ip有限责任公司 用于检测、定量和/或跟踪微生物及其他分析物的诊断测定法

Families Citing this family (458)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998034094A1 (en) 1997-01-31 1998-08-06 The Horticulture & Food Research Institute Of New Zealand Ltd. Optical apparatus
ATE273381T1 (de) * 1997-02-12 2004-08-15 Eugene Y Chan Verfahren zur analyse von polymeren
US6607829B1 (en) * 1997-11-13 2003-08-19 Massachusetts Institute Of Technology Tellurium-containing nanocrystalline materials
US6207392B1 (en) * 1997-11-25 2001-03-27 The Regents Of The University Of California Semiconductor nanocrystal probes for biological applications and process for making and using such probes
US6149867A (en) 1997-12-31 2000-11-21 Xy, Inc. Sheath fluids and collection systems for sex-specific cytometer sorting of sperm
EP2045334A1 (de) * 1998-06-24 2009-04-08 Illumina, Inc. Dekodierung von Arraysensoren mit Mikrosphären
US6617583B1 (en) * 1998-09-18 2003-09-09 Massachusetts Institute Of Technology Inventory control
US6309701B1 (en) 1998-11-10 2001-10-30 Bio-Pixels Ltd. Fluorescent nanocrystal-labeled microspheres for fluorescence analyses
US6319607B1 (en) 1998-11-10 2001-11-20 Bio-Pixels Ltd. Purification of functionalized fluorescent nanocrystals
US6261779B1 (en) * 1998-11-10 2001-07-17 Bio-Pixels Ltd. Nanocrystals having polynucleotide strands and their use to form dendrimers in a signal amplification system
US6333110B1 (en) 1998-11-10 2001-12-25 Bio-Pixels Ltd. Functionalized nanocrystals as visual tissue-specific imaging agents, and methods for fluorescence imaging
US6576155B1 (en) * 1998-11-10 2003-06-10 Biocrystal, Ltd. Fluorescent ink compositions comprising functionalized fluorescent nanocrystals
US6855202B2 (en) * 2001-11-30 2005-02-15 The Regents Of The University Of California Shaped nanocrystal particles and methods for making the same
US6306662B1 (en) * 1999-02-04 2001-10-23 Texas Tech University Fingerprint development methods
WO2000068692A1 (en) * 1999-05-07 2000-11-16 Quantum Dot Corporation A method of detecting an analyte using semiconductor nanocrystals
US6544732B1 (en) 1999-05-20 2003-04-08 Illumina, Inc. Encoding and decoding of array sensors utilizing nanocrystals
US6815218B1 (en) * 1999-06-09 2004-11-09 Massachusetts Institute Of Technology Methods for manufacturing bioelectronic devices
US7208265B1 (en) 1999-11-24 2007-04-24 Xy, Inc. Method of cryopreserving selected sperm cells
US6530944B2 (en) * 2000-02-08 2003-03-11 Rice University Optically-active nanoparticles for use in therapeutic and diagnostic methods
US6761877B2 (en) * 2000-02-18 2004-07-13 Biocrystal, Ltd. Functionalized encapsulated fluorescent nanocrystals
US6633370B2 (en) 2000-03-07 2003-10-14 Spectra Science Corporation Quantum dots, semiconductor nanocrystals and semiconductor particles used as fluorescent coding elements
US20020090650A1 (en) * 2000-04-06 2002-07-11 Quantum Dot Corporation Two-dimensional spectral imaging system
US6759235B2 (en) * 2000-04-06 2004-07-06 Quantum Dot Corporation Two-dimensional spectral imaging system
US6838243B2 (en) * 2000-04-28 2005-01-04 Quantum Dot Corporation Methods and compositions for polynucleotide analysis using generic capture sequences
WO2001091808A2 (en) * 2000-06-01 2001-12-06 The Board Of Regents For Oklahoma State University Bioconjugates of nanoparticles as radiopharmaceuticals
US20050013775A1 (en) * 2000-06-01 2005-01-20 Kotov Nicholas A. Bioconjugates of nanoparticles as radiopharmaceuticals
US20060175601A1 (en) * 2000-08-22 2006-08-10 President And Fellows Of Harvard College Nanoscale wires and related devices
KR100984585B1 (ko) * 2000-08-22 2010-09-30 프레지던트 앤드 펠로우즈 오브 하버드 칼리지 반도체 성장 방법 및 디바이스 제조 방법
US7301199B2 (en) 2000-08-22 2007-11-27 President And Fellows Of Harvard College Nanoscale wires and related devices
AU2002226876A1 (en) 2000-10-06 2002-04-15 Quantum Dot Corporation Cells having a spectral signature, and methods of preparation and use thereof
US20050059031A1 (en) 2000-10-06 2005-03-17 Quantum Dot Corporation Method for enhancing transport of semiconductor nanocrystals across biological membranes
IL138988A (en) * 2000-10-12 2005-09-25 Yissum Res Dev Co Dendritically amplified detection method
AU2002230419A1 (en) * 2000-11-08 2002-05-21 Science And Technology Corporation @Unm Fluorescence and fret based assays for biomolecules on beads
AU2002237689B2 (en) 2000-11-29 2008-01-10 Xy, Llc. System to separate frozen-thawed spermatozoa into X-chromosome bearing and Y-chromosome bearing populations
US7713687B2 (en) * 2000-11-29 2010-05-11 Xy, Inc. System to separate frozen-thawed spermatozoa into x-chromosome bearing and y-chromosome bearing populations
US7211414B2 (en) * 2000-12-01 2007-05-01 Visigen Biotechnologies, Inc. Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity
WO2002048701A2 (en) 2000-12-11 2002-06-20 President And Fellows Of Harvard College Nanosensors
WO2002076248A2 (en) * 2001-03-22 2002-10-03 Minerva Biotechnologies Corporation Customized therapeutics and in situ diagnostics
US20030113714A1 (en) * 2001-09-28 2003-06-19 Belcher Angela M. Biological control of nanoparticles
US20050164515A9 (en) * 2001-06-05 2005-07-28 Belcher Angela M. Biological control of nanoparticle nucleation, shape and crystal phase
US20030148380A1 (en) * 2001-06-05 2003-08-07 Belcher Angela M. Molecular recognition of materials
US7008559B2 (en) * 2001-06-06 2006-03-07 Nomadics, Inc. Manganese doped upconversion luminescence nanoparticles
US7501092B2 (en) * 2001-06-06 2009-03-10 Nomadics, Inc. Manganese doped upconversion luminescence nanoparticles
US20030003492A1 (en) * 2001-06-13 2003-01-02 Miller Benjamin L. Colorimetric nanocrystal sensors, methods of making, and use thereof
US20030013109A1 (en) * 2001-06-21 2003-01-16 Ballinger Clinton T. Hairpin sensors using quenchable fluorescing agents
WO2003003015A2 (en) * 2001-06-28 2003-01-09 Advanced Research And Technology Institute, Inc. Methods of preparing multicolor quantum dot tagged beads and conjugates thereof
US7473767B2 (en) 2001-07-03 2009-01-06 The Institute For Systems Biology Methods for detection and quantification of analytes in complex mixtures
US7005669B1 (en) 2001-08-02 2006-02-28 Ultradots, Inc. Quantum dots, nanocomposite materials with quantum dots, devices with quantum dots, and related fabrication methods
US6794265B2 (en) * 2001-08-02 2004-09-21 Ultradots, Inc. Methods of forming quantum dots of Group IV semiconductor materials
US6710366B1 (en) 2001-08-02 2004-03-23 Ultradots, Inc. Nanocomposite materials with engineered properties
US20030066998A1 (en) * 2001-08-02 2003-04-10 Lee Howard Wing Hoon Quantum dots of Group IV semiconductor materials
US6819845B2 (en) 2001-08-02 2004-11-16 Ultradots, Inc. Optical devices with engineered nonlinear nanocomposite materials
US7067072B2 (en) * 2001-08-17 2006-06-27 Nomadics, Inc. Nanophase luminescence particulate material
WO2003018846A1 (en) * 2001-08-31 2003-03-06 Minerva Biotechnologies Corporation Affinity tag modified particles
AU2002323168A1 (en) 2001-09-05 2003-03-18 Rensselaer Polytechnic Institute Passivated nanoparticles, method of fabrication thereof, and devices incorporating nanoparticles
US20030073104A1 (en) * 2001-10-02 2003-04-17 Belcher Angela M. Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus
JP4411078B2 (ja) * 2001-10-24 2010-02-10 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 半導体液晶組成物及びその製造方法
US7777303B2 (en) * 2002-03-19 2010-08-17 The Regents Of The University Of California Semiconductor-nanocrystal/conjugated polymer thin films
US8889414B2 (en) * 2001-10-31 2014-11-18 The Regents Of The University Of California Semiconductor nanocrystal-based phagokinetic tracking
DE10153829A1 (de) * 2001-11-05 2003-05-28 Bayer Ag Assay basierend auf dotierten Nanoteilchen
EP1442137A4 (de) * 2001-11-07 2005-08-31 Applera Corp Universelle nukleotide für die nukleinsäureanalyse
US20050118589A1 (en) 2001-11-21 2005-06-02 Vann Charles S. Digital array
US20030106488A1 (en) * 2001-12-10 2003-06-12 Wen-Chiang Huang Manufacturing method for semiconductor quantum particles
US6623559B2 (en) 2001-12-10 2003-09-23 Nanotek Instruments, Inc. Method for the production of semiconductor quantum particles
US20030129311A1 (en) * 2002-01-10 2003-07-10 Wen-Chiang Huang Method of producing quantum-dot powder and film via templating by a 2-d ordered array of air bubbles in a polymer
US20030148379A1 (en) * 2002-02-06 2003-08-07 Roitman Daniel B. Methods for making microbar encoders for bioprobes
US8271202B1 (en) 2002-02-11 2012-09-18 Fernandez Dennis S Modified host bio-data management
WO2003083478A1 (fr) * 2002-04-03 2003-10-09 Japan Science And Technology Agency Face de capteur pour biopuce porteuse de nanoparticules de polyethylene glycolate
EP1521589A4 (de) * 2002-05-07 2008-06-04 Univ California Bioaktivation von partikeln
AU2003245302A1 (en) 2002-05-17 2003-12-02 Applera Corporation Apparatus and method for differentiating multiple fluorescence signals by excitation wavelength
WO2003098279A2 (en) 2002-05-17 2003-11-27 Applera Corporation Optical instrument includung excitation source
AU2003249681A1 (en) * 2002-05-31 2003-12-19 Diversa Corporation Multiplexed systems for nucleic acid sequencing
DE10224825A1 (de) * 2002-06-05 2003-12-24 Eppendorf Ag Verfahren zur Analyse von Biomolekülen
US20070189359A1 (en) * 2002-06-12 2007-08-16 Wei Chen Nanoparticle thermometry and pressure sensors
JPWO2004007636A1 (ja) * 2002-07-16 2005-11-10 双葉電子工業株式会社 複合ナノ粒子及びその製造方法
US7049374B2 (en) 2002-07-18 2006-05-23 Chevron U.S.A. Inc. Heterodiamondoids
WO2004010552A1 (en) 2002-07-19 2004-01-29 President And Fellows Of Harvard College Nanoscale coherent optical components
EP1542529A4 (de) * 2002-07-22 2006-08-09 Xy Inc Spermazellenverfahrenssystem
US7319709B2 (en) * 2002-07-23 2008-01-15 Massachusetts Institute Of Technology Creating photon atoms
EP2275533B9 (de) 2002-08-01 2016-10-19 Xy, Llc Verfahren zur Schätzung von Spermzellen
US8486618B2 (en) 2002-08-01 2013-07-16 Xy, Llc Heterogeneous inseminate system
WO2004017041A2 (en) 2002-08-15 2004-02-26 Xy, Inc. High resolution flow cytometer
US7939170B2 (en) * 2002-08-15 2011-05-10 The Rockefeller University Water soluble metal and semiconductor nanoparticle complexes
US20040058457A1 (en) * 2002-08-29 2004-03-25 Xueying Huang Functionalized nanoparticles
CA2498003C (en) * 2002-09-06 2012-05-29 Chiron Corporation Methods for verifying fluid movement
US7534488B2 (en) * 2003-09-10 2009-05-19 The Regents Of The University Of California Graded core/shell semiconductor nanorods and nanorod barcodes
US7169548B2 (en) 2002-09-13 2007-01-30 Xy, Inc. Sperm cell processing and preservation systems
US20050064508A1 (en) * 2003-09-22 2005-03-24 Semzyme Peptide mediated synthesis of metallic and magnetic materials
US7985590B2 (en) * 2002-09-26 2011-07-26 Science Application International Corporation Method and system for detection using nanodot taggants
EP1545762A2 (de) * 2002-09-27 2005-06-29 Carlsberg A/S Räumlich kodierte polymermatrix
US9740817B1 (en) 2002-10-18 2017-08-22 Dennis Sunga Fernandez Apparatus for biological sensing and alerting of pharmaco-genomic mutation
US7035308B1 (en) 2002-10-28 2006-04-25 Science Applications International Corporation Method and system for countering laser technology
JP3640388B2 (ja) * 2002-10-29 2005-04-20 独立行政法人農業生物資源研究所 標識された核酸またはタンパク質の製造方法
AU2002952817A0 (en) * 2002-11-22 2002-12-05 St Vincent's Institute Of Medical Research Method for the detection of newly acquired hiv infection
US20040101822A1 (en) * 2002-11-26 2004-05-27 Ulrich Wiesner Fluorescent silica-based nanoparticles
US7056471B1 (en) * 2002-12-16 2006-06-06 Agency For Science Technology & Research Ternary and quarternary nanocrystals, processes for their production and uses thereof
WO2004064297A2 (en) * 2003-01-09 2004-07-29 University Of Rochester Efficient room-temperature source of polarized single photons
CA2513985C (en) * 2003-01-21 2012-05-29 Illumina Inc. Chemical reaction monitor
US7767260B2 (en) * 2003-01-22 2010-08-03 The Board Of Trustees Of The University Of Arkansas Monodisperse core/shell and other complex structured nanocrystals and methods of preparing the same
US7181266B2 (en) * 2003-03-04 2007-02-20 Massachusetts Institute Of Technology Materials and methods for near-infrared and infrared lymph node mapping
JP2007515361A (ja) * 2003-03-06 2007-06-14 レンセラー・ポリテクニック・インスティチュート ナノ粒子の、室温におけるバルク固体からの迅速な生成
ES2561816T3 (es) 2003-03-28 2016-03-01 Inguran, Llc Aparatos, métodos y procesos para clasificar partículas y para proporcionar esperma animal clasificado por sexo
US7917298B1 (en) * 2003-04-17 2011-03-29 Nanosys, Inc. Nanocrystal taggants
US8859000B2 (en) * 2003-05-05 2014-10-14 The Research Foundation Of State University Of New York Synthesis of nanoparticles by an emulsion-gas contacting process
CA2524350C (en) 2003-05-07 2015-04-14 Indiana University Research & Technology Corporation Alloyed semiconductor quantum dots and concentration-gradient alloyed quantum dots, series comprising the same and methods related thereto
CA2566749C (en) * 2003-05-15 2017-02-21 Xy, Inc. Efficient haploid cell sorting for flow cytometer systems
US20040248181A1 (en) * 2003-06-03 2004-12-09 Stenken Julie A. Method and kit for enhancing extraction and quantification of target molecules using microdialysis
US7910064B2 (en) * 2003-06-03 2011-03-22 Nanosys, Inc. Nanowire-based sensor configurations
CA2529495C (en) 2003-06-16 2013-02-05 Solx, Inc. Shunt for the treatment of glaucoma
US20060069340A1 (en) * 2003-06-16 2006-03-30 Solx, Inc. Shunt for the treatment of glaucoma
US20050019955A1 (en) * 2003-07-23 2005-01-27 Dahl Jeremy E. Luminescent heterodiamondoids as biological labels
AU2003270759A1 (en) 2003-08-04 2005-03-07 Emory University Porous materials embedded with nanospecies
CA2532991A1 (en) * 2003-08-04 2005-02-24 Nanosys, Inc. System and process for producing nanowire composites and electronic substrates therefrom
US8346482B2 (en) * 2003-08-22 2013-01-01 Fernandez Dennis S Integrated biosensor and simulation system for diagnosis and therapy
KR20060109904A (ko) * 2003-10-15 2006-10-23 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 전자 공학적, 광학적, 자기적, 반도체 및 생물 공학적용도의 지지체로서의 다기능성 생체 재료
EP1702020B1 (de) 2003-12-12 2016-04-06 Life Technologies Corporation Herstellung von stabilen, hell lumineszierenden nanopartikeln mit zusammensetzungsmässig variierbaren eigenschaften
EP1704256A4 (de) * 2004-01-13 2008-01-16 Us Genomics Inc Nachweis und quantifizierung von analyten in lösung unter verwendung von polymeren
US7645397B2 (en) * 2004-01-15 2010-01-12 Nanosys, Inc. Nanocrystal doped matrixes
JP4789809B2 (ja) * 2004-01-15 2011-10-12 サムスン エレクトロニクス カンパニー リミテッド ナノ結晶をドーピングしたマトリックス
US7312562B2 (en) * 2004-02-04 2007-12-25 Chevron U.S.A. Inc. Heterodiamondoid-containing field emission devices
US20050196790A1 (en) * 2004-02-05 2005-09-08 U.S. Genomics, Inc. Methods for detection and quantitation of minimum length polymers
US20090227107A9 (en) * 2004-02-13 2009-09-10 President And Fellows Of Havard College Nanostructures Containing Metal Semiconductor Compounds
JP5198849B2 (ja) * 2004-03-29 2013-05-15 イングラン・リミテッド・ライアビリティ・カンパニー 染色または仕分け方法において細胞内でおよび／または細胞外で酸化／還元反応を制御する組成物の使用
MXPA06011344A (es) * 2004-03-29 2006-12-15 Monsanto Technology Llc Suspensiones de espermatozoides para separar en poblaciones enriquecidas con cromosomas x o y.
US20080032420A1 (en) * 2004-03-30 2008-02-07 Lambert James L Surface Enhanced Raman Scattering and Multiplexed Diagnostic Assays
WO2006071247A2 (en) * 2004-03-30 2006-07-06 California Institute Of Technology Diagnostic assays including multiplexed lateral flow immunoassays with quantum dots
US7746681B2 (en) 2005-01-07 2010-06-29 Invisage Technologies, Inc. Methods of making quantum dot films
US7773404B2 (en) 2005-01-07 2010-08-10 Invisage Technologies, Inc. Quantum dot optical devices with enhanced gain and sensitivity and methods of making same
WO2005101530A1 (en) 2004-04-19 2005-10-27 Edward Sargent Optically-regulated optical emission using colloidal quantum dot nanocrystals
US7742322B2 (en) * 2005-01-07 2010-06-22 Invisage Technologies, Inc. Electronic and optoelectronic devices with quantum dot films
US8128908B2 (en) * 2004-04-30 2012-03-06 University Of Florida Research Foundation, Inc. Nanoparticles and their use for multifunctional bioimaging
EP1774575A2 (de) * 2004-05-17 2007-04-18 Cambrios Technology Corp. Biofabrikation von transistoren mit feldeffekttransistoren
WO2006107312A1 (en) * 2004-06-15 2006-10-12 President And Fellows Of Harvard College Nanosensors
WO2006093516A2 (en) 2004-06-22 2006-09-08 The Regents Of The University Of California Peptide-coated nanoparticles with graded shell compositions
WO2005123874A1 (ja) * 2004-06-22 2005-12-29 Fujifilm Corporation 蛍光体、蛍光体組成物及び蛍光検出方法
US20060003339A1 (en) * 2004-06-30 2006-01-05 Fuernkranz Hans A Two-hybrid system
WO2006017274A2 (en) * 2004-07-13 2006-02-16 U.S. Genomics, Inc. Systems and methods for sample modification using fluidic chambers
JPWO2006009077A1 (ja) * 2004-07-16 2008-05-01 富士フイルム株式会社 蛍光検出方法
BRPI0513685A (pt) 2004-07-22 2008-05-13 Monsanto Technology Llc processo para enriquecimento de uma população de células de esperma
US7557028B1 (en) 2004-07-28 2009-07-07 Nanosys, Inc. Process for group III-V semiconductor nanostructure synthesis and compositions made using same
JP4637565B2 (ja) * 2004-11-02 2011-02-23 一般社団法人オンチップ・セロミクス・コンソーシアム 生体試料標識物および生体物質標識法および生体物質の検査法
US7405002B2 (en) * 2004-08-04 2008-07-29 Agency For Science, Technology And Research Coated water-soluble nanoparticles comprising semiconductor core and silica coating
WO2006029302A2 (en) * 2004-09-09 2006-03-16 Applera Corporation Dioxetane-nanoparticle assemblies for energy transfer detection systems, methods of making the assemblies, and methods of using the assemblies in bioassays
US7534489B2 (en) * 2004-09-24 2009-05-19 Agency For Science, Technology And Research Coated composites of magnetic material and quantum dots
TWI353341B (en) * 2004-10-14 2011-12-01 Ibm Programmable molecular manipulating processes
US7208730B2 (en) * 2004-10-14 2007-04-24 International Business Machines Corporation Programmable molecular manipulating devices
US20060240590A1 (en) * 2004-11-09 2006-10-26 The Research Foundation Of State University Of New York Controlled synthesis of nanowires, nanodiscs, and nanostructured materials using liquid crystalline templates
JP2008520799A (ja) * 2004-11-19 2008-06-19 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ 水溶液中でのコア／シェル型半導体ナノ結晶の生成
US7524776B2 (en) * 2004-11-30 2009-04-28 Spire Corporation Surface-activation of semiconductor nanostructures for biological applications
KR20070101857A (ko) * 2004-12-06 2007-10-17 더 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 나노스케일 와이어 기반 데이터 스토리지
US20060148103A1 (en) * 2004-12-30 2006-07-06 Yin-Peng Chen Highly sensitive biological assays
US20060228726A1 (en) * 2005-01-06 2006-10-12 Martin Patrick K Polypeptides having nucleic acid binding activity and compositions and methods for nucleic acid amplification
CA2519608A1 (en) 2005-01-07 2006-07-07 Edward Sargent Quantum dot-polymer nanocomposite photodetectors and photovoltaics
KR101088147B1 (ko) * 2005-01-17 2011-12-02 에이전시 포 사이언스, 테크놀로지 앤드 리서치 신규한 수용성 나노결정 및 그 제조방법
EP1846421A4 (de) * 2005-01-20 2009-10-28 Agency Science Tech & Res Wasserlösliches, oberflächenfunktionalisiertes nanopartikel für die biokonjugation über universelle silankupplung
US20070003948A1 (en) * 2005-02-01 2007-01-04 Louise Brogan Semiconductor nanocrystal complexes and methods of detecting molecular interactions using same
US20100176343A1 (en) * 2005-02-02 2010-07-15 Wei Chen Energy-transfer nanocomposite materials and methods of making and using same
EP1869451B1 (de) 2005-03-08 2013-06-26 Life Technologies Corporation Überwachung und behandlung von zelltransmembranpotentialen mittels nanostrukturen
WO2006099386A2 (en) * 2005-03-11 2006-09-21 Massachusetts Institute Of Technology Synthesis and use of colloidal iii-v nanoparticles
WO2006105102A2 (en) * 2005-03-28 2006-10-05 The Research Foundation Of State University Of New York Synthesis of nanostructured materials using liquid crystalline templates
US20080166706A1 (en) * 2005-03-30 2008-07-10 Jin Zhang Novel gold nanoparticle aggregates and their applications
US8084001B2 (en) * 2005-05-02 2011-12-27 Cornell Research Foundation, Inc. Photoluminescent silica-based sensors and methods of use
JP2008540142A (ja) * 2005-05-04 2008-11-20 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ 低分子量コーティング試薬を含む新規な水溶性ナノ結晶、およびその調製方法
WO2006118542A1 (en) * 2005-05-04 2006-11-09 Agency For Science, Technology And Research Novel water-soluble nanocrystals comprising a polymeric coating reagent, and methods of preparing the same
US7695981B2 (en) * 2005-05-13 2010-04-13 Siluria Technologies, Inc. Seed layers, cap layers, and thin films and methods of making thereof
US7902639B2 (en) * 2005-05-13 2011-03-08 Siluria Technologies, Inc. Printable electric circuits, electronic components and method of forming the same
US20100227382A1 (en) 2005-05-25 2010-09-09 President And Fellows Of Harvard College Nanoscale sensors
WO2006132659A2 (en) * 2005-06-06 2006-12-14 President And Fellows Of Harvard College Nanowire heterostructures
DK1907583T4 (da) 2005-06-15 2020-01-27 Complete Genomics Inc Enkeltmolekyle-arrays til genetisk og kemisk analyse
US20070087360A1 (en) * 2005-06-20 2007-04-19 Boyd Victoria L Methods and compositions for detecting nucleotides
EP1905064A2 (de) * 2005-06-24 2008-04-02 Applied Nanoworks, Inc. Nanopartikel und verfahren zu ihrer herstellung
WO2007014267A2 (en) * 2005-07-26 2007-02-01 Oregon Health & Science University Nanoparticle probes for capture, sorting and placement of targets
US8101430B2 (en) * 2005-08-15 2012-01-24 Massachusetts Institute Of Technology Fluorescent sensor based on two fluorescent moieties one of which is a semiconductor nanocrystal and methods of using and making
GB0517382D0 (en) * 2005-08-26 2005-10-05 Plasticell Ltd Cell culture
US20070059713A1 (en) 2005-09-09 2007-03-15 Lee Jun E SSB-DNA polymerase fusion proteins
US20070072309A1 (en) * 2005-09-29 2007-03-29 General Electric Company Analytical compositions including nanometer-sized transducers, methods to make thereof, and devices therefrom
EP2546360A1 (de) 2005-10-07 2013-01-16 Callida Genomics, Inc. Selbstangeordnete einzelne Molekülarrays und Verwendungen davon
JP2009521666A (ja) 2005-10-12 2009-06-04 アラーガン、インコーポレイテッド 共鳴エネルギー移動後の偏光解消（ｄａｒｅｔ）を用いる分子または細胞より小さい部分の相互作用力のアッセイ
WO2007056250A2 (en) * 2005-11-04 2007-05-18 U.S. Genomics, Inc. Heterogeneous assay of analytes in solution using polymers
ES2627998T3 (es) * 2005-11-16 2017-08-01 Exchange Imaging Technologies Gmbh Nanopartículas fluorescentes
EP2308513A3 (de) * 2005-11-16 2011-11-23 Signalomics GmbH Fluoreszenz-Nanopartikel
US20090317802A1 (en) * 2005-12-09 2009-12-24 Bhatia Sangeeta N Compositions and Methods to Monitor RNA Delivery to Cells
AU2006330830B2 (en) 2005-12-23 2013-01-10 Institute For Systems Biology Nanoreporters and methods of manufacturing and use thereof
US7226752B1 (en) * 2006-01-19 2007-06-05 Avago Technologies General Ip (Singapore) Pte. Ltd. Methods for detecting an analyte in a sample
US20100255462A1 (en) * 2006-01-27 2010-10-07 Konica Minolta Medical & Graphic, Inc. Fluorescent marker for living organism and fluorescent marking method for the same
US9274108B2 (en) * 2006-02-06 2016-03-01 Massachusetts Institute Of Technology Self-assembly of macromolecules on multilayered polymer surfaces
SG10201405158QA (en) * 2006-02-24 2014-10-30 Callida Genomics Inc High throughput genome sequencing on dna arrays
EP1994180A4 (de) 2006-02-24 2009-11-25 Callida Genomics Inc Genomsequenzierung auf dna-arrays mit hohem durchsatz
US7858386B2 (en) * 2006-03-07 2010-12-28 The United States Of America As Represented By The Secretary Of The Navy Method of controlling quantum dot photoluminescence and other intrinsic properties through biological specificity
JP4568862B2 (ja) * 2006-04-14 2010-10-27 独立行政法人産業技術総合研究所 コアシェル型粒子及びその製造方法
US10522240B2 (en) 2006-05-03 2019-12-31 Population Bio, Inc. Evaluating genetic disorders
US7702468B2 (en) 2006-05-03 2010-04-20 Population Diagnostics, Inc. Evaluating genetic disorders
KR20070110995A (ko) * 2006-05-16 2007-11-21 삼성전자주식회사 반도체 나노결정-금속 복합체 및 그의 제조방법
JP2009537152A (ja) 2006-05-17 2009-10-29 カリフォルニア インスティテュート オブ テクノロジー 温度サイクルシステム
AU2007309660A1 (en) 2006-06-12 2008-05-02 President And Fellows Of Harvard College Nanosensors and related technologies
PL2046762T3 (pl) 2006-07-14 2011-07-29 Chemocentryx Inc Triazolilofenylobenzenosulfonamidy
US20080245769A1 (en) * 2006-07-17 2008-10-09 Applied Nanoworks, Inc. Nanoparticles and method of making thereof
US8058640B2 (en) 2006-09-11 2011-11-15 President And Fellows Of Harvard College Branched nanoscale wires
US9079762B2 (en) 2006-09-22 2015-07-14 Ethicon Endo-Surgery, Inc. Micro-electromechanical device
US7816669B1 (en) * 2006-10-13 2010-10-19 Hewlett-Packard Development Company, L.P. Light emitting system and methods for controlling nanocrystal distribution therein
WO2008070352A2 (en) 2006-10-27 2008-06-12 Complete Genomics, Inc. Efficient arrays of amplified polynucleotides
US7561317B2 (en) * 2006-11-03 2009-07-14 Ethicon Endo-Surgery, Inc. Resonant Fourier scanning
WO2008060455A2 (en) 2006-11-09 2008-05-22 Nanosys, Inc. Methods for nanowire alignment and deposition
US20090111706A1 (en) 2006-11-09 2009-04-30 Complete Genomics, Inc. Selection of dna adaptor orientation by amplification
EP2095100B1 (de) 2006-11-22 2016-09-21 President and Fellows of Harvard College Verfahren zum Betreiben eines Nanodraht-Feldeffekttransistorsensors
EP2099496A2 (de) * 2006-12-08 2009-09-16 Massachusetts Institute of Technology Freisetzung von nanopartikeln und/oder wirkstoffen in zellen
US20080146898A1 (en) * 2006-12-19 2008-06-19 Ethicon Endo-Surgery, Inc. Spectral windows for surgical treatment through intervening fluids
US20080151343A1 (en) * 2006-12-22 2008-06-26 Ethicon Endo-Surgery, Inc. Apparatus including a scanned beam imager having an optical dome
US7713265B2 (en) * 2006-12-22 2010-05-11 Ethicon Endo-Surgery, Inc. Apparatus and method for medically treating a tattoo
US8801606B2 (en) 2007-01-09 2014-08-12 Ethicon Endo-Surgery, Inc. Method of in vivo monitoring using an imaging system including scanned beam imaging unit
US8273015B2 (en) * 2007-01-09 2012-09-25 Ethicon Endo-Surgery, Inc. Methods for imaging the anatomy with an anatomically secured scanner assembly
US7589316B2 (en) * 2007-01-18 2009-09-15 Ethicon Endo-Surgery, Inc. Scanning beam imaging with adjustable detector sensitivity or gain
US8580735B2 (en) 2007-02-05 2013-11-12 Apellis Pharmaceuticals, Inc. Local complement inhibition for treatment of complement-mediated disorders
WO2008100885A1 (en) * 2007-02-12 2008-08-21 Evident Technologies Semiconductor nanocrystals as marking devices
JP2010518862A (ja) 2007-02-21 2010-06-03 ライフ テクノロジーズ コーポレーション 単一分子核酸配列決定のための材料および方法
US8216214B2 (en) 2007-03-12 2012-07-10 Ethicon Endo-Surgery, Inc. Power modulation of a scanning beam for imaging, therapy, and/or diagnosis
US20080226029A1 (en) * 2007-03-12 2008-09-18 Weir Michael P Medical device including scanned beam unit for imaging and therapy
US8618528B2 (en) 2007-03-20 2013-12-31 Samsung Electronics Co., Ltd. Quantum dot particles on the micron or nanometer scale and method of making the same
US20080230750A1 (en) * 2007-03-20 2008-09-25 Evident Technologies, Inc. Powdered quantum dots
US8626271B2 (en) * 2007-04-13 2014-01-07 Ethicon Endo-Surgery, Inc. System and method using fluorescence to examine within a patient's anatomy
US7995045B2 (en) 2007-04-13 2011-08-09 Ethicon Endo-Surgery, Inc. Combined SBI and conventional image processor
CA2684998A1 (en) 2007-04-30 2009-01-29 Nanogen, Inc. Multianalyte assay
US7682789B2 (en) * 2007-05-04 2010-03-23 Ventana Medical Systems, Inc. Method for quantifying biomolecules conjugated to a nanoparticle
US7892610B2 (en) * 2007-05-07 2011-02-22 Nanosys, Inc. Method and system for printing aligned nanowires and other electrical devices
US7670584B2 (en) * 2007-06-01 2010-03-02 International Business Machines Corporation Inorganic metal chalcogen cluster precursors and methods for forming colloidal metal chalcogenide nanoparticles using the same
EP2716656B1 (de) 2007-06-15 2016-10-12 Xiamen University An Hämagglutinin des Vogelgrippevirus Subtyp H5 bindende monoklonale Antikörper und Verwendung dafür
US8160678B2 (en) 2007-06-18 2012-04-17 Ethicon Endo-Surgery, Inc. Methods and devices for repairing damaged or diseased tissue using a scanning beam assembly
US7776877B2 (en) * 2007-06-22 2010-08-17 Chemocentryx, Inc. N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
US7558455B2 (en) * 2007-06-29 2009-07-07 Ethicon Endo-Surgery, Inc Receiver aperture broadening for scanned beam imaging
US7816135B2 (en) 2007-07-05 2010-10-19 Becton, Dickinson And Company Method of analyzing lymphocytes
WO2009009630A1 (en) * 2007-07-11 2009-01-15 Clemson University Photoluminescent materials for multiphoton imaging
ES2383568T3 (es) * 2007-07-12 2012-06-22 Chemocentryx, Inc. Heteroaril piridil y fenil bencenosulfonamidas condensadas como moduladores de CCR2 para el tratamiento de la inflamación
US7982776B2 (en) * 2007-07-13 2011-07-19 Ethicon Endo-Surgery, Inc. SBI motion artifact removal apparatus and method
US20090021818A1 (en) * 2007-07-20 2009-01-22 Ethicon Endo-Surgery, Inc. Medical scanning assembly with variable image capture and display
US9125552B2 (en) * 2007-07-31 2015-09-08 Ethicon Endo-Surgery, Inc. Optical scanning module and means for attaching the module to medical instruments for introducing the module into the anatomy
US7983739B2 (en) 2007-08-27 2011-07-19 Ethicon Endo-Surgery, Inc. Position tracking and control for a scanning assembly
US7925333B2 (en) 2007-08-28 2011-04-12 Ethicon Endo-Surgery, Inc. Medical device including scanned beam unit with operational control features
EP2034002B1 (de) * 2007-09-04 2013-07-17 Samsung Electronics Co., Ltd. Nanokristall-Metalloxid-Verbundstoffe und Herstellungsverfahren dafür
US8947516B2 (en) * 2007-09-26 2015-02-03 Massachusetts Institute Of Technology High-resolution 3D imaging of single semiconductor nanocrystals
US8168958B2 (en) * 2007-10-18 2012-05-01 The Invention Science Fund I, Llc Ionizing-radiation-responsive compositions, methods, and systems
US8164074B2 (en) * 2007-10-18 2012-04-24 The Invention Science Fund I, Llc Ionizing-radiation-responsive compositions, methods, and systems
GB2453860B (en) 2007-10-18 2011-03-16 Searete Llc Ionizing-radiation-responsive compositions,methods and systems
US8227204B2 (en) * 2007-10-18 2012-07-24 The Invention Science Fund I, Llc Ionizing-radiation-responsive compositions, methods, and systems
US8684898B2 (en) * 2007-10-18 2014-04-01 The Invention Science Fund I Llc Ionizing-radiation-responsive compositions, methods, and systems
US9557635B2 (en) * 2007-10-18 2017-01-31 Gearbox, Llc Ionizing-radiation-responsive compositions, methods, and systems
US20090104113A1 (en) * 2007-10-18 2009-04-23 Searete Llc Ionizing-radiation-responsive compositions, methods, and systems
US8529426B2 (en) 2007-10-18 2013-09-10 The Invention Science Fund I Llc Ionizing-radiation-responsive compositions, methods, and systems
US9551026B2 (en) 2007-12-03 2017-01-24 Complete Genomincs, Inc. Method for nucleic acid detection using voltage enhancement
US20090196852A1 (en) * 2008-02-04 2009-08-06 Watkinson D Tobin Compositions and methods for diagnosing and treating immune disorders
US10996218B2 (en) 2008-03-11 2021-05-04 Ournextbaby Llc Methods for chemotaxis / redox driven separation of X and Y chromosome bearing sperm and their insemination in gender specific menstrual cycles
WO2009113374A1 (ja) * 2008-03-14 2009-09-17 コニカミノルタエムジー株式会社 標識方法
US8050520B2 (en) * 2008-03-27 2011-11-01 Ethicon Endo-Surgery, Inc. Method for creating a pixel image from sampled data of a scanned beam imager
WO2009123767A1 (en) 2008-04-04 2009-10-08 Life Technologies Corporation Scanning system and method for imaging and sequencing
US8332014B2 (en) * 2008-04-25 2012-12-11 Ethicon Endo-Surgery, Inc. Scanned beam device and method using same which measures the reflectance of patient tissue
CN102119331A (zh) 2008-06-05 2011-07-06 生命科技公司 细胞跨膜电位的激活和监测
US20100090164A1 (en) * 2008-06-10 2010-04-15 Xiaogang Peng Indium arsenide nanocrystals and methods of making the same
WO2010002922A2 (en) * 2008-06-30 2010-01-07 Life Technologies Corporation Methods for isolating and purifying nanoparticles from a complex medium
WO2010003059A2 (en) 2008-07-02 2010-01-07 Life Technologies Corporation Stable indium-containing semiconductor nanocrystals
GB0813273D0 (en) * 2008-07-19 2008-08-27 Nanoco Technologies Ltd Method for producing aqueous compatible nanoparticles
EP2331704B1 (de) 2008-08-14 2016-11-30 Nanostring Technologies, Inc Stabile nanoreporter
CA2679750A1 (en) 2008-09-23 2010-03-23 Nexus Dx, Inc. Methods for detecting nucleic acids in a sample
KR101462656B1 (ko) * 2008-12-16 2014-11-17 삼성전자 주식회사 나노입자/블록공중합체 복합체의 제조방법
EP2382470B1 (de) 2009-01-29 2014-12-10 Commonwealth Scientific and Industrial Research Organisation Messung der aktivierung eines g-protein-gekoppelten rezeptors
US20100261185A1 (en) 2009-03-27 2010-10-14 Life Technologies Corporation Labeled enzyme compositions, methods and systems
WO2010115160A2 (en) 2009-04-03 2010-10-07 Helixis, Inc. Devices and methods for heating biological samples
US8053744B2 (en) * 2009-04-13 2011-11-08 Src, Inc. Location analysis using nucleic acid-labeled tags
JP2012528020A (ja) 2009-05-26 2012-11-12 ナノシス・インク． ナノワイヤおよび他のデバイスの電場沈着のための方法およびシステム
GB0914195D0 (en) 2009-08-13 2009-09-16 Plasticell Ltd Vessel for culturing cells
CN101993467B (zh) * 2009-08-24 2015-12-09 香港科技大学 在纳米颗粒表面控制功能分子密度的方法
US8987685B2 (en) 2009-09-09 2015-03-24 Pcr Max Limited Optical system for multiple reactions
US9297796B2 (en) 2009-09-24 2016-03-29 President And Fellows Of Harvard College Bent nanowires and related probing of species
EP2488876B1 (de) 2009-10-13 2017-03-01 Nanostring Technologies, Inc Proteinnachweis über nanoreporter
GB0918564D0 (en) 2009-10-22 2009-12-09 Plasticell Ltd Nested cell encapsulation
EP2519647A1 (de) 2009-12-31 2012-11-07 Ventana Medical Systems, Inc. Verfahren zur herstellung von eindeutig spezifischen nukleinsäuresonden
WO2011100541A2 (en) 2010-02-11 2011-08-18 Nanostring Technologies, Inc. Compositions and methods for the detection of small rnas
US9410891B2 (en) 2010-02-19 2016-08-09 Pacific Biosciences Of California, Inc. Optics collection and detection system and method
EP2539355B1 (de) 2010-02-26 2016-10-05 Ventana Medical Systems, Inc. In-situ hybridisierung mit polytag-sonden
US20120301885A1 (en) 2010-02-26 2012-11-29 Lei Tang Cytogenic analysis of metaphase chromosomes
US9069130B2 (en) 2010-05-03 2015-06-30 The General Hospital Corporation Apparatus, method and system for generating optical radiation from biological gain media
CA2798703A1 (en) 2010-05-10 2011-11-17 The Regents Of The University Of California Endoribonuclease compositions and methods of use thereof
US8703493B2 (en) 2010-06-15 2014-04-22 Src, Inc. Location analysis using fire retardant-protected nucleic acid-labeled tags
WO2012007725A2 (en) 2010-07-16 2012-01-19 Plasticell Ltd Method of reprogramming a cell
US8862410B2 (en) 2010-08-02 2014-10-14 Population Diagnostics, Inc. Compositions and methods for discovery of causative mutations in genetic disorders
US8716027B2 (en) 2010-08-03 2014-05-06 Src, Inc. Nucleic acid-labeled tags associated with odorant
US20120034603A1 (en) 2010-08-06 2012-02-09 Tandem Diagnostics, Inc. Ligation-based detection of genetic variants
US20130261003A1 (en) 2010-08-06 2013-10-03 Ariosa Diagnostics, In. Ligation-based detection of genetic variants
WO2012036691A1 (en) 2010-09-16 2012-03-22 Urobiologics Llc Use of female mammal's urine for determination of fetal gender related characteristics
US9525092B2 (en) 2010-11-05 2016-12-20 Pacific Light Technologies Corp. Solar module employing quantum luminescent lateral transfer concentrator
EP3396032B1 (de) 2010-12-28 2021-02-24 Life Technologies Corporation Herstellung von nanokristallen mit mischungen aus organischen liganden
US8871670B2 (en) * 2011-01-05 2014-10-28 The Board Of Trustees Of The University Of Illinois Defect engineering in metal oxides via surfaces
US10131947B2 (en) 2011-01-25 2018-11-20 Ariosa Diagnostics, Inc. Noninvasive detection of fetal aneuploidy in egg donor pregnancies
US20120190021A1 (en) 2011-01-25 2012-07-26 Aria Diagnostics, Inc. Detection of genetic abnormalities
WO2012118745A1 (en) 2011-02-28 2012-09-07 Arnold Oliphant Assay systems for detection of aneuploidy and sex determination
CA2825453C (en) 2011-03-14 2016-05-10 Ventana Medical Systems, Inc. A method of analyzing chromosomal translocations and a system therefore
US9758834B2 (en) 2011-03-28 2017-09-12 Nanostring Technologies, Inc. Compositions and methods for diagnosing cancer
US8741564B2 (en) 2011-05-04 2014-06-03 Htg Molecular Diagnostics, Inc. Quantitative nuclease protection assay (QNPA) and sequencing (QNPS) improvements
DK2766483T3 (da) 2011-10-10 2022-04-19 Hospital For Sick Children Fremgangsmåder og sammensætninger til screening for og behandling af udviklingsforstyrrelser
EP2766498B1 (de) 2011-10-14 2019-06-19 President and Fellows of Harvard College Sequenzierung durch strukturanordnung
WO2013057586A1 (en) 2011-10-19 2013-04-25 Oslo Universitetssykehus Hf Compositions and methods for producing soluble t - cell receptors
US10837879B2 (en) 2011-11-02 2020-11-17 Complete Genomics, Inc. Treatment for stabilizing nucleic acid arrays
EP2773779B1 (de) 2011-11-04 2020-10-14 Population Bio, Inc. Verfahren und zusammensetzungen zur diagnose, prognose und behandlung neurologischer erkrankungen
US20130112942A1 (en) 2011-11-09 2013-05-09 Juanita Kurtin Composite having semiconductor structures embedded in a matrix
WO2013108126A2 (en) 2012-01-16 2013-07-25 University Of Oslo Methyltransferases and uses thereof
DK2812452T3 (da) 2012-02-09 2020-06-29 Population Bio Inc Fremgangsmåder og sammensætninger til screening og behandling af udviklingsforstyrrelser
ES2645617T3 (es) 2012-02-29 2017-12-07 Chemocentryx, Inc. Pirazol-1-il benceno sulfonamidas como antagonistas del CCR9
WO2013167387A1 (en) 2012-05-10 2013-11-14 Ventana Medical Systems, Inc. Uniquely specific probes for pten, pik3ca, met, top2a, and mdm2
AU2013266394B2 (en) 2012-05-21 2019-03-14 The Scripps Research Institute Methods of sample preparation
WO2013184754A2 (en) 2012-06-05 2013-12-12 President And Fellows Of Harvard College Spatial sequencing of nucleic acids using dna origami probes
US9488823B2 (en) 2012-06-07 2016-11-08 Complete Genomics, Inc. Techniques for scanned illumination
US9628676B2 (en) 2012-06-07 2017-04-18 Complete Genomics, Inc. Imaging systems with movable scan mirrors
US9139770B2 (en) 2012-06-22 2015-09-22 Nanosys, Inc. Silicone ligands for stabilizing quantum dot films
TWI596188B (zh) 2012-07-02 2017-08-21 奈米系統股份有限公司 高度發光奈米結構及其製造方法
PL2872646T3 (pl) 2012-07-12 2018-03-30 Institut National De La Santé Et De La Recherche Médicale (Inserm) Sposoby przewidywania czasu przeżycia i responsywności na leczenie pacjenta cierpiącego na nowotwór lity z sygnaturą przynajmniej 7 genów
DK2820418T3 (en) 2012-07-20 2018-02-12 Harvard College Cell-based quality control bioassays for nutraceutical and medical products
EP2895621B1 (de) 2012-09-14 2020-10-21 Population Bio, Inc. Verfahren und zusammensetzungen zur diagnose, prognose und behandlung neurologischer erkrankungen
WO2014048942A1 (en) 2012-09-25 2014-04-03 Ventana Medical Systems, Inc. Probes for pten, pik3ca, met, and top2a, and method for using the probes
EP2900835A4 (de) 2012-09-27 2016-05-11 Population Diagnotics Inc Verfahren und zusammensetzungen zum screening und zur behandlung von entwicklungsstörungen
US9476089B2 (en) 2012-10-18 2016-10-25 President And Fellows Of Harvard College Methods of making oligonucleotide probes
US11366061B2 (en) 2013-01-24 2022-06-21 Grace Bio-Labs, Inc. Protein microarray assay imager
WO2014134338A1 (en) * 2013-03-01 2014-09-04 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University Oligonucleotide functionalized quantum dots
US8945827B2 (en) 2013-03-13 2015-02-03 Awareness Technology, Inc. Serological methods and diagnostic tests for syphilis antibodies
KR102203599B1 (ko) 2013-03-14 2021-01-14 나노시스, 인크. 무용매 양자점 교환 방법
US9540685B2 (en) 2013-03-15 2017-01-10 President And Fellows Of Harvard College Methods of identifying homologous genes using FISH
WO2015036405A1 (en) 2013-09-10 2015-03-19 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for diagnosing and treating basal cell carcinoma
EP3066218B1 (de) 2013-11-05 2018-12-26 HTG Molecular Diagnostics, Inc. Nachweisverfahren für nukleinsäuren
EP2891722B1 (de) 2013-11-12 2018-10-10 Population Bio, Inc. Verfahren und Zusammensetzungen zur Diagnose, Prognose und Behandlung von Endometriose
JP6407286B2 (ja) 2013-12-17 2018-10-17 スリーエム イノベイティブ プロパティズ カンパニー フタル酸誘導体を含む複合ナノ粒子
EP3083879B1 (de) 2013-12-17 2018-10-03 3M Innovative Properties Company Verbundnanopartikel mit einem malonsäurederivat
US10001480B2 (en) 2014-01-31 2018-06-19 Jan J. Dubowski Photo-electrochemical biosensor and semiconductor heterostructure-based sensing method
EP3110966A1 (de) 2014-02-24 2017-01-04 Ventana Medical Systems, Inc. Automatisierter rna-nachweis mit markierten 2'-o-methyl-rns-oligonukleotidsonden und signalverstärkungssystemen
CN107075546B (zh) 2014-08-19 2021-08-31 哈佛学院董事及会员团体 用于对核酸探测并作图的rna-引导的系统
CA2996445A1 (en) 2014-09-05 2016-03-10 Eli Hatchwell Methods and compositions for inhibiting and treating neurological conditions
CA2960821A1 (en) 2014-09-09 2016-03-17 Igenomx International Genomics Corporation Methods and compositions for rapid nucleic acid library preparation
CN107002137A (zh) * 2014-09-22 2017-08-01 加利福尼亚大学董事会 单分子rna检测
MA40592A (fr) 2014-10-06 2016-04-14 Chemocentryx Inc Compositions et méthodes pour le traitement d'une maladie inflammatoire de l'intestin à l'aide d'une polythérapie à base d'inhibiteurs à petites molécules de récepteur 9 de chimiokine c-c (ccr9) et d'anticorps bloquants anti-intégrine alpha4beta7
EP3009147A1 (de) 2014-10-16 2016-04-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Verfahren zur Behandlung von resistenten Glioblastomen
ES2770055T3 (es) 2014-11-21 2020-06-30 Nanostring Technologies Inc Secuenciación sin enzima ni amplificación
EP3227661A4 (de) 2014-12-05 2019-01-09 Inguran, LLC Verarbeitung von zellen unter verwendung magnetischer partikel
WO2016113233A1 (en) 2015-01-12 2016-07-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the diagnosis of pancreatic cancer
FR3035716B1 (fr) * 2015-04-30 2019-06-21 Biomerieux Machine et procede pour la detection automatisee in vitro d'analytes mettant en oeuvre une decomposition spectrale chromatique d'une reponse optique
EP3325649B1 (de) 2015-07-17 2024-01-03 Nanostring Technologies, Inc. Gleichzeitigen quantifizierung einer vielzahl von proteinen in einer benutzerdefinierten region eines gewebequerschnitts
AU2016295158B2 (en) 2015-07-17 2021-02-25 Nanostring Technologies, Inc. Simultaneous quantification of gene expression in a user-defined region of a cross-sectioned tissue
WO2017029391A1 (en) 2015-08-20 2017-02-23 INSERM (Institut National de la Santé et de la Recherche Médicale) New method for treating cancer
WO2017055319A1 (en) 2015-09-29 2017-04-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for quantifying the population of b cells in a tissue sample
WO2017055325A1 (en) 2015-09-29 2017-04-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for quantifying the population of nk cells in a tissue sample
WO2017055321A1 (en) 2015-09-29 2017-04-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for quantifying the population of fibroblasts in a tissue sample
WO2017055322A1 (en) 2015-09-29 2017-04-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for quantifying the population of neutrophils in a tissue sample
WO2017055324A1 (en) 2015-09-29 2017-04-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for quantifying the population of cells of monocytic origin in a tissue sample
WO2017055320A1 (en) 2015-09-29 2017-04-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for quantifying the population of cytotoxic lymphocytes in a tissue sample
WO2017055326A1 (en) 2015-09-29 2017-04-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for quantifying the population of myeloid dendritic cells in a tissue sample
WO2017055327A1 (en) 2015-09-29 2017-04-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for quantifying the population of endothelial cells in a tissue sample
WO2017060397A1 (en) 2015-10-09 2017-04-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting the survival time of subjects suffering from melanoma metastases
WO2017067944A1 (en) 2015-10-19 2017-04-27 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting the survival time of subjects suffering from triple negative breast cancer
JP7094880B2 (ja) 2015-11-06 2022-07-04 ヴェンタナ メディカル システムズ， インク． 代表診断法
ES2761266T3 (es) 2015-11-10 2020-05-19 Inst Nat Sante Rech Med Métodos para predicción del tiempo de supervivencia de los pacientes con cirrosis alcohólica descompensada
WO2017122039A1 (en) 2016-01-13 2017-07-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting pancreatic cancer treatment response
TW201806625A (zh) 2016-03-30 2018-03-01 康瓦鐵克科技股份有限公司 經修飾之傷口敷料
WO2017182834A1 (en) 2016-04-19 2017-10-26 INSERM (Institut National de la Santé et de la Recherche Médicale) New method for treating resistant glioblastoma
CA3023566A1 (en) 2016-05-16 2017-11-23 Nanostring Technologies, Inc. Methods for detecting target nucleic acids in a sample
EP3463452A1 (de) 2016-05-24 2019-04-10 Institut National de la Sante et de la Recherche Medicale (INSERM) Verfahren und pharmazeutische zusammensetzungen zur behandlung von nicht-kleinzelligem lungenkrebs (nsclc), der mit chronisch obstruktiver lungenerkrankung (copd) koexistiert
EP3469098A1 (de) 2016-06-14 2019-04-17 INSERM - Institut National de la Santé et de la Recherche Médicale Verfahren zur vorhersage der reaktion auf die behandlung von akuter schwerer kolitis
WO2018011107A1 (en) 2016-07-11 2018-01-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of er-alpha 46 in methods and kits for assessing the status of breast cancer
WO2018011166A2 (en) 2016-07-12 2018-01-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for quantifying the population of myeloid dendritic cells in a tissue sample
WO2018046736A1 (en) 2016-09-12 2018-03-15 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting the survival time of patients suffering from cancer
WO2018046738A1 (en) 2016-09-12 2018-03-15 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting the survival time of patients suffering from cancer
WO2018054960A1 (en) 2016-09-21 2018-03-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting and treating resistance to chemotherapy in npm-alk(+) alcl
WO2018055080A1 (en) 2016-09-22 2018-03-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for reprograming immune environment in a subject in need thereof
US11725232B2 (en) 2016-10-31 2023-08-15 The Hong Kong University Of Science And Technology Compositions, methods and kits for detection of genetic variants for alzheimer's disease
JP6730525B2 (ja) 2016-11-21 2020-07-29 ナノストリング テクノロジーズ，インコーポレイティド 化学組成物とそれを利用する方法
MX2021014356A (es) 2016-11-23 2022-11-24 Chemocentryx Inc Metodo para tratar glomeruloesclerosis segmentaria focal.
WO2018122249A1 (en) 2016-12-28 2018-07-05 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting the survival time of patients suffering from a microsatellite stable colorectal cancer
WO2018122245A1 (en) 2016-12-28 2018-07-05 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods of predicting the survival time of patients suffering from cms3 colorectal cancer
US10240205B2 (en) 2017-02-03 2019-03-26 Population Bio, Inc. Methods for assessing risk of developing a viral disease using a genetic test
WO2018146239A1 (en) 2017-02-10 2018-08-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Biomarker for outcome in aml patients
WO2018162404A1 (en) 2017-03-06 2018-09-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Biomarker for outcome in aml patients
WO2018172540A1 (en) 2017-03-24 2018-09-27 INSERM (Institut National de la Santé et de la Recherche Médicale) Method to predict the progression of alzheimer's disease
EP3601613B1 (de) 2017-03-29 2021-12-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Verfahren zur beurteilung eines schwangerschaftsergebnisses
WO2018189215A1 (en) 2017-04-12 2018-10-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for predicting the survival time of a patient suffering from hepatocellular carcinoma
JP7270254B2 (ja) 2017-06-16 2023-05-10 デューク ユニバーシティ 改善された標識検出、演算、検体感知、および調整可能な乱数生成のための共鳴体ネットワーク
WO2019038219A1 (en) 2017-08-21 2019-02-28 INSERM (Institut National de la Santé et de la Recherche Médicale) NEW PROGNOSTIC METHOD OF PANCREATIC CANCER
WO2019043138A1 (en) 2017-09-01 2019-03-07 INSERM (Institut National de la Santé et de la Recherche Médicale) METHOD FOR PREDICTING OUTCOME OF CANCER
AU2018347361A1 (en) 2017-10-11 2020-04-30 Chemocentryx, Inc. Treatment of focal segmental glomerulosclerosis with CCR2 antagonists
CN111656179B (zh) 2017-11-13 2023-11-03 豪夫迈·罗氏有限公司 用于使用表位电泳进行样品分析的装置
WO2019104070A1 (en) 2017-11-21 2019-05-31 Nanostring Technologies, Inc. O-nitrobenzyl photocleavable bifunctional linker
WO2019118652A1 (en) 2017-12-12 2019-06-20 Essenlix Corporation Sample manipulation and assay with rapid temperature change
EP3752635A1 (de) 2018-02-12 2020-12-23 Nanostring Technologies, Inc. Biomolekulare sonden und verfahren zur detektion von gen- und proteinexpression
WO2019207030A1 (en) 2018-04-26 2019-10-31 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting a response with an immune checkpoint inhibitor in a patient suffering from a lung cancer
JP2021523723A (ja) 2018-05-14 2021-09-09 ナノストリング テクノロジーズ，インコーポレイティド 化学的組成物とそれを利用する方法
WO2019229489A1 (en) 2018-05-31 2019-12-05 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of mir-146a-5p and mir-186 as biomarkers of osteoarthritis
EP3814492A4 (de) 2018-06-29 2022-02-23 Wuhan Neurophth Biotechnology Limited Company Zusammensetzungen und verfahren zur behandlung der leberschen optikusatrophie
WO2020001657A1 (en) 2018-06-29 2020-01-02 Wuhan Neurophth Biological Technology Limited Company Compositions and methods for treating leber's hereditary optic neuropathy
EP3625368B8 (de) 2018-08-08 2022-12-14 PML Screening, LLC Verfahren zur beurteilung des risikos der entwicklung von durch john-cunningham-virus verursachter progressiver multifokaler leukenzephalopathie durch genetisches testen
SG11202101032VA (en) 2018-08-20 2021-02-25 Wuhan Neurophth Biotechnology Ltd Company Compositions and methods for treating leber's hereditary optic neuropathy
WO2020041360A1 (en) 2018-08-21 2020-02-27 Quidel Corporation Dbpa antibodies and uses thereof
WO2020089432A1 (en) 2018-11-02 2020-05-07 INSERM (Institut National de la Santé et de la Recherche Médicale) New prognostic method of pancreatic cancer
WO2020089428A1 (en) 2018-11-02 2020-05-07 INSERM (Institut National de la Santé et de la Recherche Médicale) New prognostic method of pancreatic cancer
WO2020141199A1 (en) 2019-01-03 2020-07-09 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for enhancing cd8+ t cell-dependent immune responses in subjects suffering from cancer
WO2020148349A1 (en) 2019-01-16 2020-07-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Variants of erythroferrone and their use
US20220098674A1 (en) 2019-02-13 2022-03-31 Inserm (Institut National De La Santé Et Dr La Recherch Médicale) Methods and compositions for selecting a cancer treatment in a subject suffering from cancer
WO2020182932A1 (en) 2019-03-13 2020-09-17 INSERM (Institut National de la Santé et de la Recherche Médicale) New gene signatures for predicting survival time in patients suffering from renal cell carcinoma
CA3133622C (en) 2019-03-19 2024-04-23 Inguran, Llc Method for improved sperm cell populations
WO2020193740A1 (en) 2019-03-28 2020-10-01 INSERM (Institut National de la Santé et de la Recherche Médicale) New strategy for treating pancreatic cancer
WO2020201362A2 (en) 2019-04-02 2020-10-08 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods of predicting and preventing cancer in patients having premalignant lesions
US20220211741A1 (en) 2019-04-18 2022-07-07 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the treatment and prognosis of cancer
EP3959340A1 (de) 2019-04-24 2022-03-02 Institut National de la Santé et de la Recherche Médicale (INSERM) Verfahren zur vorhersage der reaktion von antipsychotischen wirkstoffen
WO2020229521A1 (en) 2019-05-14 2020-11-19 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for inhibiting or reducing bacterial biofilms on a surface
WO2020229437A1 (en) 2019-05-14 2020-11-19 F. Hoffmann-La Roche Ag Devices and methods for sample analysis
WO2021001539A1 (en) 2019-07-04 2021-01-07 INSERM (Institut National de la Santé et de la Recherche Médicale) New strategy to detect and treat eosinophilic fasciitis
US20220340975A1 (en) 2019-09-05 2022-10-27 INSERM (Institute National de la Santé et de la Recherche Médicale) Method of treatment and pronostic of acute myeloid leukemia
WO2021063968A1 (en) 2019-09-30 2021-04-08 INSERM (Institut National de la Santé et de la Recherche Médicale) Method and composition for diagnosing chronic obstructive pulmonary disease
WO2021074391A1 (en) 2019-10-17 2021-04-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for diagnosing nasal intestinal type adenocarcinomas
JP2022552013A (ja) 2019-10-18 2022-12-14 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 臨床規模および工業規模の無傷の組織の配列決定
US10792360B1 (en) 2019-11-21 2020-10-06 Chemocentryx, Inc. Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-TNF-alpha blocking antibodies
CN113025633A (zh) 2019-12-09 2021-06-25 武汉纽福斯生物科技有限公司 编码人nadh脱氢酶亚单位1蛋白的核酸及其应用
EP4104186A1 (de) 2020-02-13 2022-12-21 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH Verfahren zur automatischen semantikbasierten funktionellen gewebekommentierung histologischer und zellulärer merkmale zur identifizierung von molekularen merkmalen in gewebeproben
EP4110955A1 (de) 2020-02-28 2023-01-04 INSERM (Institut National de la Santé et de la Recherche Médicale) Verfahren zur diagnose, prognose und verwaltung der behandlung von brustkrebs
WO2021186014A1 (en) 2020-03-20 2021-09-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for predicting the survival time of a patient suffering from a cancer
TW202203916A (zh) 2020-03-31 2022-02-01 美商卡默森屈有限公司 使用ｃｃｒ９抑制劑及抗ｉｌ—２３阻斷抗體治療發炎性腸道疾病的組成物及方法
WO2021250106A1 (en) 2020-06-10 2021-12-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for treating and prognosing cancer like glioblastoma
EP4168006A1 (de) 2020-06-18 2023-04-26 Institut National de la Santé et de la Recherche Médicale (INSERM) Neue strategie zur behandlung von bauchspeicheldrüsenkrebs
WO2022018163A1 (en) 2020-07-22 2022-01-27 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for predicting survival time in patients suffering from cancer
US20230366012A1 (en) 2020-09-16 2023-11-16 Nanostring Technologies, Inc. Chemical compositions and methods of using the same
WO2022064049A1 (en) 2020-09-28 2022-03-31 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for diagnosing brucella infection
US20230383350A1 (en) 2020-10-20 2023-11-30 Institut National De La Sante Et De La Recherche Medicale Method for predicting the response to tnf inhibitors
US20240011094A1 (en) 2020-11-06 2024-01-11 Institut National de la Santé et de la Recherche Médicale Methods for diagnosis and treating polycystic ovary syndrome (pcos)
WO2022135753A1 (en) 2020-12-21 2022-06-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for prognosis the humoral response of a subject prior to vaccination
WO2022136252A1 (en) 2020-12-21 2022-06-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for prognosis the humoral response of a subject prior to vaccination
WO2022152698A1 (en) 2021-01-12 2022-07-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of npdk-d to evaluate cancer prognosis
US20220228200A1 (en) 2021-01-19 2022-07-21 10X Genomics, Inc. Methods and compositions for internally controlled in situ assays
US20240044901A1 (en) 2021-02-09 2024-02-08 Institut National de la Santé et de la Recherche Médicale New method to pronostic lung cancer
US20240159760A1 (en) 2021-03-17 2024-05-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for diagnosing pancreatic cancer
WO2022207566A1 (en) 2021-03-29 2022-10-06 INSERM (Institut National de la Santé et de la Recherche Médicale) New method to evaluate pancreatic cancer prognosis
US20240158861A1 (en) 2021-04-23 2024-05-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for treating cell senescence accumulation related disease
US20220380838A1 (en) 2021-06-01 2022-12-01 10X Genomics, Inc. Methods and compositions for analyte detection and probe resolution
CN117751197A (zh) 2021-06-02 2024-03-22 10X基因组学有限公司 使用不对称可环化探针的样品分析
WO2023280790A1 (en) 2021-07-05 2023-01-12 INSERM (Institut National de la Santé et de la Recherche Médicale) Gene signatures for predicting survival time in patients suffering from renal cell carcinoma
WO2023288225A1 (en) 2021-07-13 2023-01-19 10X Genomics, Inc. Methods for preparing polymerized matrix with controllable thickness
US20230057571A1 (en) 2021-08-03 2023-02-23 10X Genomics, Inc. Nucleic acid concatemers and methods for stabilizing and/or compacting the same
CA3228344A1 (en) 2021-08-06 2023-02-09 Wuhan Neurophth Biotechnology Limited Company Composition and method for treating leber's hereditary optic neuropathy caused by nd4 mutation
WO2023023484A1 (en) 2021-08-16 2023-02-23 10X Genomics, Inc. Probes comprising a split barcode region and methods of use
WO2023089159A1 (en) 2021-11-22 2023-05-25 INSERM (Institut National de la Santé et de la Recherche Médicale) New strategy targeting stroma/tumor cell crosstalk to treat a cancer
US20230242974A1 (en) 2021-12-27 2023-08-03 10X Genomics, Inc. Methods and compositions for rolling circle amplification
US20230279475A1 (en) 2022-01-21 2023-09-07 10X Genomics, Inc. Multiple readout signals for analyzing a sample
WO2023144303A1 (en) 2022-01-31 2023-08-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Cd38 as a biomarker and biotarget in t-cell lymphomas
WO2023152133A1 (en) 2022-02-08 2023-08-17 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for diagnosing colorectal cancer
WO2023164570A1 (en) 2022-02-23 2023-08-31 Insitro, Inc. Pooled optical screening and transcriptional measurements of cells comprising barcoded genetic perturbations
WO2023192616A1 (en) 2022-04-01 2023-10-05 10X Genomics, Inc. Compositions and methods for targeted masking of autofluorescence
US20240002902A1 (en) 2022-05-06 2024-01-04 10X Genomics, Inc. Analysis of antigen and antigen receptor interactions
US20240026427A1 (en) 2022-05-06 2024-01-25 10X Genomics, Inc. Methods and compositions for in situ analysis of v(d)j sequences
WO2023220300A1 (en) 2022-05-11 2023-11-16 10X Genomics, Inc. Compositions and methods for in situ sequencing
WO2023245190A1 (en) 2022-06-17 2023-12-21 10X Genomics, Inc. Catalytic de-crosslinking of samples for in situ analysis
WO2024036304A1 (en) 2022-08-12 2024-02-15 10X Genomics, Inc. Puma1 polymerases and uses thereof
US20240084373A1 (en) 2022-08-16 2024-03-14 10X Genomics, Inc. Ap50 polymerases and uses thereof
WO2024061930A1 (en) 2022-09-22 2024-03-28 Institut National de la Santé et de la Recherche Médicale New method to treat and diagnose peripheral t-cell lymphoma (ptcl)
WO2024081869A1 (en) 2022-10-14 2024-04-18 10X Genomics, Inc. Methods for analysis of biological samples
WO2024102736A1 (en) 2022-11-08 2024-05-16 10X Genomics, Inc. Immobilization methods and compositions for in situ detection
US20240158852A1 (en) 2022-11-16 2024-05-16 10X Genomics, Inc. Methods and compositions for assessing performance of in situ assays
WO2024115935A1 (en) 2022-11-29 2024-06-06 Inserm Methods for the treatment of b-cell lymphoma using cd39 inhibitors

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262357A (en) 1991-11-22 1993-11-16 The Regents Of The University Of California Low temperature thin films formed from nanocrystal precursors
US5505928A (en) 1991-11-22 1996-04-09 The Regents Of University Of California Preparation of III-V semiconductor nanocrystals
US5571018A (en) 1994-11-23 1996-11-05 Motorola, Inc. Arrangement for simulating indirect fire in combat training
WO1998004740A1 (en) * 1996-07-29 1998-02-05 Nanosphere Llc Nanoparticles having oligonucleotides attached thereto and uses therefor
US5990479A (en) * 1997-11-25 1999-11-23 Regents Of The University Of California Organo Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
EP0990903A1 (de) * 1998-09-18 2000-04-05 Massachusetts Institute Of Technology Biologische Verwendungen von halbleitenden Nanokristallen

Family Cites Families (173)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US692786A (en) * 1901-07-20 1902-02-04 Nellie F Smith Coin-operated vending-machine.
US3954666A (en) 1974-07-11 1976-05-04 E. I. Du Pont De Nemours And Company Semipermeable microcapsules containing heterogeneous catalysts and ferromagnetic materials
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
FR2403646A1 (fr) 1977-09-16 1979-04-13 Anvar Procede de realisation d'un depot de compose semi-conducteur d'elements iii et v
US4238195A (en) 1979-01-18 1980-12-09 Miles Laboratories, Inc. Fluorescer-labeled specific binding assays
US4637988A (en) 1981-07-01 1987-01-20 Eastman Kodak Company Fluorescent labels for immunoassay
WO1983004123A1 (en) 1982-05-19 1983-11-24 Matsushita Electric Industrial Co., Ltd. Electroluminescent display unit
US4594264A (en) 1984-11-20 1986-06-10 Hughes Aircraft Company Method for forming gallium arsenide from thin solid films of gallium-arsenic complexes
US5101827A (en) 1985-07-05 1992-04-07 Immunomedics, Inc. Lymphographic and organ imaging method and kit
US4738932A (en) 1985-12-03 1988-04-19 Advanced Polymer Systems, Inc. Reaginic test for syphilis
US4802951A (en) 1986-03-07 1989-02-07 Trustees Of Boston University Method for parallel fabrication of nanometer scale multi-device structures
US4777128A (en) 1986-05-27 1988-10-11 Ethigen Corporation Fluorescence immunoassay involving energy transfer between two fluorophores
US4827945A (en) 1986-07-03 1989-05-09 Advanced Magnetics, Incorporated Biologically degradable superparamagnetic materials for use in clinical applications
US4798701A (en) 1987-07-13 1989-01-17 International Business Machines Corporation Method of synthesizing amorphous group IIIA-group VA compounds
WO1990005998A1 (en) 1988-11-21 1990-05-31 Mitsui Toatsu Chemicals, Inc. Light-emitting element
US5304786A (en) 1990-01-05 1994-04-19 Symbol Technologies, Inc. High density two-dimensional bar code symbol
US5114703A (en) 1989-05-30 1992-05-19 Alliance Pharmaceutical Corp. Percutaneous lymphography using particulate fluorocarbon emulsions
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
WO1991006894A1 (en) 1989-10-18 1991-05-16 Research Corporation Technologies, Inc. Plasmon enhanced photo processes
GR1000686B (el) 1989-11-16 1992-10-08 Ortho Diagnostic Systems Inc Μεθοδος παραγωγης ενος αντιδραστηριου κολλοειδους μεταλλου που περιεχει κολλοειδη τεμαχιδια μεταλλου με προκαθορισμενο μεγεθος. εθος.
JPH03258866A (ja) 1990-03-07 1991-11-19 Nippon Sheet Glass Co Ltd ポリジメチルシロキサン被覆微粒子
US5460831A (en) 1990-06-22 1995-10-24 The Regents Of The University Of California Targeted transfection nanoparticles
US5219577A (en) 1990-06-22 1993-06-15 The Regents Of The University Of California Biologically active composition having a nanocrystalline core
US5084128A (en) 1990-10-23 1992-01-28 E. I. Du Pont De Nemours And Company Low-temperature synthesis of group III-group V semiconductors
US5147841A (en) 1990-11-23 1992-09-15 The United States Of America As Represented By The United States Department Of Energy Method for the preparation of metal colloids in inverse micelles and product preferred by the method
US5212426A (en) 1991-01-24 1993-05-18 Motorola, Inc. Integrally controlled field emission flat display device
DE4117782C2 (de) 1991-05-28 1997-07-17 Diagnostikforschung Inst Nanokristalline magnetische Eisenoxid-Partikel, Verfahren zu ihrer Herstellung sowie diagnostische und/oder therapeutische Mittel
JP3125332B2 (ja) 1991-06-21 2001-01-15 ソニー株式会社 量子ドットトンネル素子とそれを用いた情報処理装置及び情報処理方法
WO1993006121A1 (en) 1991-09-18 1993-04-01 Affymax Technologies N.V. Method of synthesizing diverse collections of oligomers
JP2970967B2 (ja) 1991-11-20 1999-11-02 浜松ホトニクス株式会社 蛍光性プローブ試薬を用いた細胞内イオン濃度測定法
JPH07502479A (ja) 1991-11-22 1995-03-16 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 自己集合性単一層を使って固体無機表面に共有結合した半導体微少結晶
US5515393A (en) 1992-01-29 1996-05-07 Sony Corporation Semiconductor laser with ZnMgSSe cladding layers
DE69328929T2 (de) 1992-05-22 2000-11-02 Minnesota Mining & Mfg Ii-vi laserdioden mit durch atomlagen- und migrationsverstaerkte epitaxie aufgewachsenen quantum wells
EP0645048A1 (de) 1992-06-08 1995-03-29 BioQuest Incorporated Herstellung anorganischer teilchen von kontrollierter grösse zur verwendung in trennverfahren, als magnetische molekulare schalter und als anorganischeliposomen für medizinische anwendungen
US5674698A (en) 1992-09-14 1997-10-07 Sri International Up-converting reporters for biological and other assays using laser excitation techniques
ES2123063T3 (es) 1992-09-14 1999-01-01 Stanford Res Inst Int Marcadores convertidores al alza para ensayos biologicos y otros mediante tecnicas de excitacion laser.
US5565324A (en) 1992-10-01 1996-10-15 The Trustees Of Columbia University In The City Of New York Complex combinatorial chemical libraries encoded with tags
US5721099A (en) 1992-10-01 1998-02-24 Trustees Of Columbia University In The City Of New York Complex combinatorial chemical libraries encoded with tags
US5260957A (en) 1992-10-29 1993-11-09 The Charles Stark Draper Laboratory, Inc. Quantum dot Laser
GB9223334D0 (en) 1992-11-06 1992-12-23 Hybaid Ltd Magnetic solid phase supports
US5429824A (en) 1992-12-15 1995-07-04 Eastman Kodak Company Use of tyloxapole as a nanoparticle stabilizer and dispersant
US5308804A (en) 1992-12-15 1994-05-03 Lee Huai Chuan Moving disks made of semiconductor nanocrystallite embedded glass
US5293050A (en) 1993-03-25 1994-03-08 International Business Machines Corporation Semiconductor quantum dot light emitting/detecting devices
EP0622439A1 (de) * 1993-04-20 1994-11-02 Koninklijke Philips Electronics N.V. Dotierte halbleitfähige Partikel mit Quantenskala-Aktivator versehen
US6048616A (en) * 1993-04-21 2000-04-11 Philips Electronics N.A. Corp. Encapsulated quantum sized doped semiconductor particles and method of manufacturing same
US5442254A (en) 1993-05-04 1995-08-15 Motorola, Inc. Fluorescent device with quantum contained particle screen
JPH0750448A (ja) 1993-08-04 1995-02-21 Matsushita Electric Ind Co Ltd 半導体レーザおよびその製造方法
JPH0794034A (ja) * 1993-09-22 1995-04-07 Fujitsu Ltd フラットケーブル及びこれを用いたコネクタ付ケーブル
GB9323498D0 (en) 1993-11-15 1994-01-05 Isis Innovation Making particles of uniform size
US5445489A (en) * 1994-10-14 1995-08-29 At&T Ipm Corp. Heavy load transporter with improved jacks
US5492080A (en) 1993-12-27 1996-02-20 Matsushita Electric Industrial Co., Ltd. Crystal-growth method and semiconductor device production method using the crystal-growth method
US5422489A (en) 1994-01-24 1995-06-06 Bhargava; Rameshwar N. Light emitting device
US5474591A (en) 1994-01-31 1995-12-12 Duke University Method of synthesizing III-V semiconductor nanocrystals
US5434878A (en) 1994-03-18 1995-07-18 Brown University Research Foundation Optical gain medium having doped nanocrystals of semiconductors and also optical scatterers
US5881886A (en) 1994-03-18 1999-03-16 Brown University Research Foundation Optically-based methods and apparatus for sorting garments and other textiles
US5448582A (en) 1994-03-18 1995-09-05 Brown University Research Foundation Optical sources having a strongly scattering gain medium providing laser-like action
US5559057A (en) 1994-03-24 1996-09-24 Starfire Electgronic Development & Marketing Ltd. Method for depositing and patterning thin films formed by fusing nanocrystalline precursors
US5455489A (en) 1994-04-11 1995-10-03 Bhargava; Rameshwar N. Displays comprising doped nanocrystal phosphors
GB2318666B (en) 1994-04-25 1998-07-15 Univ Hertfordshire Coded items for labelling objects
US5537000A (en) * 1994-04-29 1996-07-16 The Regents, University Of California Electroluminescent devices formed using semiconductor nanocrystals as an electron transport media and method of making such electroluminescent devices
US6159445A (en) 1994-07-20 2000-12-12 Nycomed Imaging As Light imaging contrast agents
US5677545A (en) 1994-09-12 1997-10-14 Motorola Organic light emitting diodes with molecular alignment and method of fabrication
KR970706628A (ko) 1994-09-29 1997-11-03 로버츠 사이먼 크리스토퍼 양자 도트가 있는 광섬유(optical fibre with quantum dots)
WO1996014206A1 (en) 1994-11-08 1996-05-17 Spectra Science Corporation Semiconductor nanocrystal display materials and display apparatus employing same
US5541948A (en) 1994-11-28 1996-07-30 The Regents Of The University Of California Transition-metal doped sulfide, selenide, and telluride laser crystal and lasers
US5985353A (en) 1994-12-01 1999-11-16 University Of Massachusetts Lowell Biomolecular synthesis of quantum dot composites
US5786139A (en) 1994-12-09 1998-07-28 Panvera Corporation Method and kit for detecting nucleic acid cleavage utilizing a covalently attached fluorescent tag
US5585640A (en) 1995-01-11 1996-12-17 Huston; Alan L. Glass matrix doped with activated luminescent nanocrystalline particles
US5747180A (en) 1995-05-19 1998-05-05 University Of Notre Dame Du Lac Electrochemical synthesis of quasi-periodic quantum dot and nanostructure arrays
US5656707A (en) * 1995-06-16 1997-08-12 Regents Of The University Of Minnesota Highly cross-linked polymeric supports
EP0762370A3 (de) 1995-08-02 1998-01-07 Canon Kabushiki Kaisha Ansteuerungsverfahren für ein Anzeigegerät mit optischer Modulationsvorrichtung
GB9518910D0 (en) 1995-09-15 1995-11-15 Imperial College Process
US5932309A (en) 1995-09-28 1999-08-03 Alliedsignal Inc. Colored articles and compositions and methods for their fabrication
US5711803A (en) 1995-09-29 1998-01-27 Midwest Research Institute Preparation of a semiconductor thin film
US5736330A (en) 1995-10-11 1998-04-07 Luminex Corporation Method and compositions for flow cytometric determination of DNA sequences
DE19541028C2 (de) 1995-11-05 1998-01-22 Daimler Benz Ag Effektlack mit Pigmenten, die eine Kennzeichnung tragen, sowie Verfahren zu seiner Herstellung
US5876480A (en) 1996-02-20 1999-03-02 The United States Of America As Represented By The Secretary Of The Navy Synthesis of unagglomerated metal nano-particles at membrane interfaces
US6506564B1 (en) 1996-07-29 2003-01-14 Nanosphere, Inc. Nanoparticles having oligonucleotides attached thereto and uses therefor
US6582921B2 (en) 1996-07-29 2003-06-24 Nanosphere, Inc. Nanoparticles having oligonucleotides attached thereto and uses thereof
US6984491B2 (en) 1996-07-29 2006-01-10 Nanosphere, Inc. Nanoparticles having oligonucleotides attached thereto and uses therefor
US7169556B2 (en) 1996-07-29 2007-01-30 Nanosphere, Inc. Nanoparticles having oligonucleotides attached thereto and uses therefor
US6361944B1 (en) 1996-07-29 2002-03-26 Nanosphere, Inc. Nanoparticles having oligonucleotides attached thereto and uses therefor
US7098320B1 (en) 1996-07-29 2006-08-29 Nanosphere, Inc. Nanoparticles having oligonucleotides attached thereto and uses therefor
US6750016B2 (en) 1996-07-29 2004-06-15 Nanosphere, Inc. Nanoparticles having oligonucleotides attached thereto and uses therefor
DE19630581A1 (de) 1996-07-30 1998-02-05 Studiengesellschaft Kohle Mbh Verfahren zur Herstellung von Solvens-stabilisierten Metallkolloiden und trägerfixierten Metallclustern
US5846517A (en) 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
US5908608A (en) 1996-11-08 1999-06-01 Spectra Science Corporation Synthesis of metal chalcogenide quantum
US5922537A (en) 1996-11-08 1999-07-13 N.o slashed.AB Immunoassay, Inc. Nanoparticles biosensor
US6103868A (en) 1996-12-27 2000-08-15 The Regents Of The University Of California Organically-functionalized monodisperse nanocrystals of metals
US5939021A (en) 1997-01-23 1999-08-17 Hansen; W. Peter Homogeneous binding assay
AU6271798A (en) 1997-02-18 1998-09-08 Spectra Science Corporation Field activated security thread including polymer dispersed liquid crystal
US6023540A (en) 1997-03-14 2000-02-08 Trustees Of Tufts College Fiber optic sensor with encoded microspheres
US6106609A (en) * 1997-04-08 2000-08-22 The United States Of America As Represented By The Secretary Of The Navy Formation of nanocrystalline semiconductor particles within a bicontinuous cubic phase
DE19721601A1 (de) 1997-05-23 1998-11-26 Hoechst Ag Polybetain-stabilisierte, Palladium-haltige Nanopartikel, ein Verfahren zu ihrer Herstellung sowie daraus hergestellte Katalysatoren zur Gewinnung von Vinylacetat
US6055053A (en) 1997-06-02 2000-04-25 Stress Photonics, Inc. Full field photoelastic stress analysis
US6165440A (en) 1997-07-09 2000-12-26 Board Of Regents, The University Of Texas System Radiation and nanoparticles for enhancement of drug delivery in solid tumors
JP4071360B2 (ja) 1997-08-29 2008-04-02 株式会社東芝 半導体装置
KR20010031140A (ko) 1997-10-14 2001-04-16 루미넥스 코포레이션 정밀 형광염료 입자 및 그의 제조방법 그리고 그의 사용
AUPP004497A0 (en) 1997-10-28 1997-11-20 University Of Melbourne, The Stabilized particles
DE69724474T2 (de) 1997-11-13 2004-06-24 The Procter & Gamble Company, Cincinnati Bekleidung zum gebrauch mit einem absorbierenden artikel
US6607829B1 (en) 1997-11-13 2003-08-19 Massachusetts Institute Of Technology Tellurium-containing nanocrystalline materials
US6322901B1 (en) 1997-11-13 2001-11-27 Massachusetts Institute Of Technology Highly luminescent color-selective nano-crystalline materials
US5985173A (en) 1997-11-18 1999-11-16 Gray; Henry F. Phosphors having a semiconductor host surrounded by a shell
US6005707A (en) 1997-11-21 1999-12-21 Lucent Technologies Inc. Optical devices comprising polymer-dispersed crystalline materials
US6207392B1 (en) 1997-11-25 2001-03-27 The Regents Of The University Of California Semiconductor nanocrystal probes for biological applications and process for making and using such probes
US6699723B1 (en) 1997-11-25 2004-03-02 The Regents Of The University Of California Organo luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
US5952665A (en) 1997-11-28 1999-09-14 Nanocrystals Technology L.P. Composite nanophosphor screen for detecting radiation
US6252254B1 (en) 1998-02-06 2001-06-26 General Electric Company Light emitting device with phosphor composition
US6139585A (en) 1998-03-11 2000-10-31 Depuy Orthopaedics, Inc. Bioactive ceramic coating and method
US6501091B1 (en) 1998-04-01 2002-12-31 Massachusetts Institute Of Technology Quantum dot white and colored light emitting diodes
US6864626B1 (en) 1998-06-03 2005-03-08 The Regents Of The University Of California Electronic displays using optically pumped luminescent semiconductor nanocrystals
US6159742A (en) 1998-06-05 2000-12-12 President And Fellows Of Harvard College Nanometer-scale microscopy probes
US6337117B1 (en) 1998-07-01 2002-01-08 Mitsubishi Chemical Corporation Optical memory device
US6262129B1 (en) 1998-07-31 2001-07-17 International Business Machines Corporation Method for producing nanoparticles of transition metals
US6294401B1 (en) 1998-08-19 2001-09-25 Massachusetts Institute Of Technology Nanoparticle-based electrical, chemical, and mechanical structures and methods of making same
US6251303B1 (en) 1998-09-18 2001-06-26 Massachusetts Institute Of Technology Water-soluble fluorescent nanocrystals
US6326144B1 (en) 1998-09-18 2001-12-04 Massachusetts Institute Of Technology Biological applications of quantum dots
PT1116036E (pt) 1998-09-18 2004-10-29 Massachusetts Inst Technology Nanocristais semicondutores fluorescentes soluveis em agua
US6426513B1 (en) 1998-09-18 2002-07-30 Massachusetts Institute Of Technology Water-soluble thiol-capped nanocrystals
US6617583B1 (en) 1998-09-18 2003-09-09 Massachusetts Institute Of Technology Inventory control
US6306610B1 (en) 1998-09-18 2001-10-23 Massachusetts Institute Of Technology Biological applications of quantum dots
JP2000104058A (ja) 1998-09-28 2000-04-11 Sony Corp 発光体の製造方法
US6114038A (en) 1998-11-10 2000-09-05 Biocrystal Ltd. Functionalized nanocrystals and their use in detection systems
AU1717600A (en) 1998-11-10 2000-05-29 Biocrystal Limited Methods for identification and verification
WO2000027365A1 (en) 1998-11-10 2000-05-18 Biocrystal Limited Functionalized nanocrystals and their use in detection systems
WO2000028089A1 (en) 1998-11-10 2000-05-18 Biocrystal Limited Functionalized nanocrystals and their use in labeling for strand synthesis or sequence determination
US6261779B1 (en) 1998-11-10 2001-07-17 Bio-Pixels Ltd. Nanocrystals having polynucleotide strands and their use to form dendrimers in a signal amplification system
US6309701B1 (en) 1998-11-10 2001-10-30 Bio-Pixels Ltd. Fluorescent nanocrystal-labeled microspheres for fluorescence analyses
WO2000027436A1 (en) 1998-11-10 2000-05-18 Biocrystal Limited Functionalized nanocrystals as visual tissue-specific imaging agents, and methods for fluorescence imaging
AU2965500A (en) 1999-01-15 2000-08-01 Gene Logic, Inc. Immobilized nucleic acid hybridization reagent and method
US6444192B1 (en) 1999-02-05 2002-09-03 The Regents Of The University Of California Diagnostic imaging of lymph structures
US6167297A (en) 1999-05-05 2000-12-26 Benaron; David A. Detecting, localizing, and targeting internal sites in vivo using optical contrast agents
US6410255B1 (en) 1999-05-05 2002-06-25 Aurora Biosciences Corporation Optical probes and assays
WO2000068692A1 (en) 1999-05-07 2000-11-16 Quantum Dot Corporation A method of detecting an analyte using semiconductor nanocrystals
US6696299B1 (en) 1999-05-11 2004-02-24 Massachusetts Institute Of Technology Polarization label for measuring 3-dimensional orientation
EP1198462B1 (de) * 1999-06-03 2004-09-29 Eli Lilly And Company Verfahren zur herstellung von 10,11methanodibenzosuberanderivaten
CA2374337C (en) 1999-07-26 2009-04-14 Massachusetts Institute Of Technology Tellurium-containing nanocrystalline materials
EP1202671A4 (de) 1999-08-13 2004-11-10 Point Biomedical Corp Mikropartikel verwendbar als ultraschallkontrastmittel für das lymphsystem
US6179912B1 (en) 1999-12-20 2001-01-30 Biocrystal Ltd. Continuous flow process for production of semiconductor nanocrystals
WO2001051665A2 (en) 2000-01-13 2001-07-19 Nanosphere Inc. Nanoparticles having oligonucleotides attached thereto and uses therefor
US6225198B1 (en) 2000-02-04 2001-05-01 The Regents Of The University Of California Process for forming shaped group II-VI semiconductor nanocrystals, and product formed using process
US6306736B1 (en) 2000-02-04 2001-10-23 The Regents Of The University Of California Process for forming shaped group III-V semiconductor nanocrystals, and product formed using process
US6530944B2 (en) 2000-02-08 2003-03-11 Rice University Optically-active nanoparticles for use in therapeutic and diagnostic methods
US6633370B2 (en) 2000-03-07 2003-10-14 Spectra Science Corporation Quantum dots, semiconductor nanocrystals and semiconductor particles used as fluorescent coding elements
CA2406983A1 (en) 2000-03-14 2001-09-27 Massachusetts Institute Of Technology A gain medium and lasers based on close-packed semiconductor nanocrystals
CA2403620C (en) 2000-03-20 2012-01-10 Massachusetts Institute Of Technology Inorganic chromophore bioconjugates
US6653080B2 (en) 2000-03-22 2003-11-25 Quantum Dot Corporation Loop probe hybridization assay for polynucleotide analysis
US6797412B1 (en) 2000-04-11 2004-09-28 University Of Connecticut Full color display structures using pseudomorphic cladded quantum dot nanophosphor thin films
JP2001299676A (ja) 2000-04-25 2001-10-30 Fuji Photo Film Co Ltd センチネルリンパ節検出方法および検出システム
US6947979B1 (en) 2000-08-16 2005-09-20 Entrust, Inc. Controlling use of a network resource
AU2002211807A1 (en) 2000-09-11 2002-03-26 Massachusetts Institute Of Technology Direct haplotyping using carbon nanotube probes
JP2002095663A (ja) 2000-09-26 2002-04-02 Fuji Photo Film Co Ltd センチネルリンパ節光断層画像取得方法および装置
CA2424415C (en) 2000-10-04 2010-09-28 The Board Of Trustees Of The University Of Arkansas Synthesis of colloidal nanocrystals
US6576291B2 (en) 2000-12-08 2003-06-10 Massachusetts Institute Of Technology Preparation of nanocrystallites
US20040105973A1 (en) 2001-03-09 2004-06-03 Igor Nabiev Ultrasensitive non-isotopic water-soluble nanocrystals
US6846565B2 (en) 2001-07-02 2005-01-25 Board Of Regents, The University Of Texas System Light-emitting nanoparticles and method of making same
AU2002367778A1 (en) 2001-07-20 2003-11-10 Quantum Dot Corporation Luminescent nanoparticles and methods for their preparation
JP2005502176A (ja) 2001-09-04 2005-01-20 コーニンクレッカ　フィリップス　エレクトロニクス　エヌ　ヴィ 量子ドットを有するエレクトロルミネセント装置
US8889414B2 (en) 2001-10-31 2014-11-18 The Regents Of The University Of California Semiconductor nanocrystal-based phagokinetic tracking
US6744361B1 (en) * 2001-12-10 2004-06-01 Harold Maddox Vehicular safety brake light system
WO2003065394A2 (en) 2002-01-25 2003-08-07 Konarka Technologies, Inc. Photovoltaic cell components and materials
US7189417B2 (en) 2002-05-01 2007-03-13 The Trustees Of The University Of Pennsylvania Nanometer-sized carrier medium
AU2003304433A1 (en) 2002-08-02 2005-03-07 Ultradots, Inc. Quantum dots, nanocomposite materials with quantum dots, optical devices with quantum dots, and related fabrication methods
JP2006502232A (ja) 2002-08-15 2006-01-19 モウンギ ジー． バウエンディ 安定化された半導体ナノクリスタル
US7939170B2 (en) 2002-08-15 2011-05-10 The Rockefeller University Water soluble metal and semiconductor nanoparticle complexes
JP2004077389A (ja) 2002-08-21 2004-03-11 Hitachi Software Eng Co Ltd 半導体ナノ粒子を含む機能性蛍光試薬
US6938993B2 (en) 2002-10-31 2005-09-06 Benq Corporation Fluid injection head structure
US7500953B2 (en) 2003-01-25 2009-03-10 Seno Medical Instruments, Inc. High contrast optoacoustic imaging using nanoparticles
US20050020922A1 (en) 2003-03-04 2005-01-27 Frangioni John V. Materials and methods for near-infrared and infrared intravascular imaging
US7181266B2 (en) 2003-03-04 2007-02-20 Massachusetts Institute Of Technology Materials and methods for near-infrared and infrared lymph node mapping
US20050038498A1 (en) 2003-04-17 2005-02-17 Nanosys, Inc. Medical device applications of nanostructured surfaces
US20040265622A1 (en) 2003-06-24 2004-12-30 Eastman Kodak Company Light emitting display
US20050220714A1 (en) 2004-04-01 2005-10-06 Susan Kauzlarich Agents for use in magnetic resonance and optical imaging

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262357A (en) 1991-11-22 1993-11-16 The Regents Of The University Of California Low temperature thin films formed from nanocrystal precursors
US5505928A (en) 1991-11-22 1996-04-09 The Regents Of University Of California Preparation of III-V semiconductor nanocrystals
US5571018A (en) 1994-11-23 1996-11-05 Motorola, Inc. Arrangement for simulating indirect fire in combat training
WO1998004740A1 (en) * 1996-07-29 1998-02-05 Nanosphere Llc Nanoparticles having oligonucleotides attached thereto and uses therefor
US5990479A (en) * 1997-11-25 1999-11-23 Regents Of The University Of California Organo Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
EP0990903A1 (de) * 1998-09-18 2000-04-05 Massachusetts Institute Of Technology Biologische Verwendungen von halbleitenden Nanokristallen

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
BRUCHEZ M JR ET AL: "Semiconductor nanocrystals as fluorescent biological labels", SCIENCE,US,AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, vol. 281, no. 281, 25 September 1998 (1998-09-25), pages 2013 - 2016-2016, XP002125872, ISSN: 0036-8075 *
CHAN WCW ET AL: "Quantum Dot bioconjugates for ultrasensitive nonisotopic detection", SCIENCE,US,AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, vol. 281, no. 281, 25 September 1998 (1998-09-25), pages 2016 - 2018-2018, XP002125871, ISSN: 0036-8075 *
DABBOUSI B O: "(CDSE)ZNS CORE-SHELL QUANTUM DOTS: SYNTHESIS AND CHARACTERIZATIONS OF A SIZE SERIES OF HIGHLY LUMINESCENT NANOCRYSTALLITES", JOURNAL OF PHYSICAL CHEMISTRY. B, MATERIALS, SURFACES, INTERFACES AND BIOPHYSICAL,US,WASHINGTON, DC, vol. 101, no. 46, 13 November 1997 (1997-11-13), pages 9463 - 9475, XP002095418, ISSN: 1089-5647 *
DABBOUSI ET AL.: "(CdSe) ZnS Core-Shell Quantum Dots: Synthesis and Characterization of a Size Series of Highly Luminescent Nanocrystals", JOURNAL OF PHYSICAL CHEMISTRY, vol. 101, 1997, pages 9463 - 9475, XP002539979, DOI: doi:10.1021/jp971091y
GREG HERMANSON: "Bioconjugate Techniques", ACADEMIC PRESS
LACOSTE T.D. ET AL.: "Super resolution molecular ruler using single quantum dots", BIOPHYSICAL JOURNAL, vol. 78, January 2000 (2000-01-01), pages 402A, XP000933548 *
PENG; SCHLAMP; KADAVANICH; ALIVISATOS: "Epitaxial Growth of Highly Luminescent CdSe/CdS Core/Shell Nanocrystals with Photostability and Electronic Accessibility", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 119, no. 30, 1997, pages 7019 - 7029
R.P.HAUGLAND: "Handbook of Fluorescent Probes and Research Chemicals(6th edition)", MOLECULAR PROBES, INC.

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9284188B2 (en) 2010-09-03 2016-03-15 The Regents Of The University Of California Cytosolic delivery of materials with endosome-disrupting colloids
CN111051884A (zh) * 2017-05-18 2020-04-21 轨迹农业Ip有限责任公司 用于检测、定量和/或跟踪微生物及其他分析物的诊断测定法
EP3625563A4 (de) * 2017-05-18 2021-02-24 Locus Agriculture IP Company, LLC Diagnostische tests zum nachweis, zur quantifizierung und/oder zur verfolgung von mikroben und anderen analyten

Also Published As

Publication number Publication date
US8639449B2 (en) 2014-01-28
JP2002539454A (ja) 2002-11-19
WO2000055631A1 (en) 2000-09-21
US20140179046A1 (en) 2014-06-26
EP2287614B1 (de) 2013-08-07
US8288152B2 (en) 2012-10-16
US20100155668A1 (en) 2010-06-24
JP4601828B2 (ja) 2010-12-22
EP2180321B1 (de) 2014-10-08
US20090191567A1 (en) 2009-07-30
US8071359B2 (en) 2011-12-06
US20020072234A1 (en) 2002-06-13
CA2366303A1 (en) 2000-09-21
EP2180321A1 (de) 2010-04-28
US8071361B2 (en) 2011-12-06
CA2366303C (en) 2010-01-12
JP2010275311A (ja) 2010-12-09
US20110275169A1 (en) 2011-11-10
US20070111350A1 (en) 2007-05-17
US6727065B2 (en) 2004-04-27
US8288153B2 (en) 2012-10-16
US20030099968A1 (en) 2003-05-29
US20090253211A1 (en) 2009-10-08
US20170323998A1 (en) 2017-11-09
US6207392B1 (en) 2001-03-27
US20100224853A1 (en) 2010-09-09
AU3712700A (en) 2000-10-04
US8071360B2 (en) 2011-12-06
EP1166118A1 (de) 2002-01-02
US9530928B2 (en) 2016-12-27

Similar Documents

Publication Publication Date Title
EP2287614B1 (de) Halbleiternanokrystallinesonden für biologischen Anwendungen
US6927069B2 (en) Organo luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
US6699723B1 (en) Organo luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
US8110407B2 (en) Fluorescent semiconductor microparticle assembly, fluorescent labeling agent assembly for biological substance, and bioimaging method and biological substance analysis method using the assemblies
JP2005528466A (ja) 種々の発光強度及び周波数を有する発光性の球状非自己蛍光性シリカゲル
Bruchez Jr Luminescent semiconductor nanocrystals: Intermittent behavior and use as fluorescent biological probes
JP2000275180A (ja) 生物学的用途のための有機発光半導体ナノクリスタルプローブ、およびこのようなプローブを製造および使用するプロセス
WO2002099425A2 (en) Polymeric bead probe with nanocrystal, manufacture and use of the same
Nann et al. Bio–Nano-Systems
JP2009175161A (ja) 生物学的用途のための有機発光半導体ナノクリスタルプローブ、およびこのようなプローブを製造および使用するプロセス

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AC Divisional application: reference to earlier application

Ref document number: 2180321

Country of ref document: EP

Kind code of ref document: P

Ref document number: 1166118

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIN1 Information on inventor provided before grant (corrected)

Inventor name: BRUCHEZ, MARCEL

Inventor name: ALVISATOS, PAUL

Inventor name: WEISS, SHIMON

17P Request for examination filed

Effective date: 20110506

17Q First examination report despatched

Effective date: 20110926

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AC Divisional application: reference to earlier application

Ref document number: 1166118

Country of ref document: EP

Kind code of ref document: P

Ref document number: 2180321

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: AT

Ref legal event code: REF

Ref document number: 625977

Country of ref document: AT

Kind code of ref document: T

Effective date: 20130815

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 60048188

Country of ref document: DE

Effective date: 20131002

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 625977

Country of ref document: AT

Kind code of ref document: T

Effective date: 20130807

REG Reference to a national code

Ref country code: NL

Ref legal event code: VDEP

Effective date: 20130807

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131209

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130807

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130918

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130807

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130807

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130807

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130807

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131108

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130807

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130807

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130807

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130807

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20140508

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 60048188

Country of ref document: DE

Effective date: 20140508

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130807

Ref country code: LU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140228

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140228

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140228

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140228

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 17

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 18

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20190227

Year of fee payment: 20

Ref country code: DE

Payment date: 20190227

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20190225

Year of fee payment: 20

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 60048188

Country of ref document: DE

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Expiry date: 20200227

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20200227